Corneal nerves in refractive surgery and dry eye by Tuisku, Ilpo
1Department of Ophthalmology
University of Helsinki
Helsinki, Finland
CORNEAL NERVES IN REFRACTIVE
SURGERY AND DRY EYE
ILPO S. TUISKU
Academic Dissertation
To be publicly discussed,
with the permission of the Medical Faculty of the University of Helsinki,
 in Lecture Hall 2 of Biomedicum, Haartmaninkatu 8,
 Helsinki, on February 22nd, 2008, at 12 noon.
Helsinki 2008
2Supervised by:
Professor Timo Tervo
Department of Ophthalmology
University of Helsinki
FINLAND
Reviewed by:
Professor Hannu Uusitalo
Department of Ophthalmology
University of Tampere
FINLAND
and
Professor Marja-Liisa Vuori
Department of Ophthalmology
University of Turku
FINLAND
Opponent:
Professor Friedrich Kruse
Department of Ophthalmology
University of Erlangen-Nürnberg
GERMANY
© Ilpo S. Tuisku
ISBN 978-952-92-3307-6 (paperback)
ISBN 978-952-10-4500-4 (PDF)
Yliopistopaino
Helsinki 2008
3To Johanna, Tom, and Matias
4CONTENTS
LIST OF ORIGINAL PUBLICATIONS 6
ABBREVIATIONS   7
ABSTRACT 9
INTRODUCTION 10
REVIEW OF THE LITERATURE 11
1. Corneal structure 11
2. Corneal innervation and sensitivity 13
3. Neurosecretorial regulation of tearing 15
4. Tear fluid cytokines 16
5. Corneal wound healing 17
6. Antigen-presenting cells 20
7. Excimer laser 20
8. Photorefractive keratectomy – PRK 21
8.1  Nerve regeneration after PRK 22
8.2  Corneal sensitivity after PRK 23
9. Laser in situ keratomileusis – LASIK 23
9.1  Nerve regeneration after LASIK 24
9.2  Corneal sensitivity after LASIK 25
10. Dry eye 27
11. Dry eye after refractive surgery 29
12. Sjögren’s syndrome 30
12.1 Neurological manifestations in Sjögren’s syndrome 31
AIMS OF THE STUDY 32
SUBJECTS AND METHODS 33
1. Subjects 33
1.1 PRK patients 33
1.2 LASIK patients and controls 33
1.3 Primary Sjögren’s syndrome patients and controls 34
52. Methods 35
2.1 Clinical examination 35
2.2 Tear fluid analysis 36
2.3 In vivo confocal microscopy –  IVCM 38
2.4 Noncontact esthesiometry 39
2.5 PRK 40
2.6 LASIK 40
2.7 Statistical analyses 41
RESULTS 42
1. Tear fluid cytokines, haze, and nerve regeneration after PRK 42
1.1 Tear fluid cytokines after PRK 42
1.2 IVCM three months after PRK 42
1.3 Correlations between IVCM data and cytokines 44
2. Dry eye and corneal sensitivity after high myopic LASIK 44
2.1 Subjective symptoms 44
2.2 Objective dry eye tests 44
2.3 Corneal sensitivity 45
3. Corneal morphology and sensitivity in primary Sjögren’s syndrome 45
3.1 Subjective symptoms 45
3.2 Objective dry eye tests 45
3.3 Corneal sensitivity 46
3.4 IVCM in primary Sjögren’s syndrome 46
DISCUSSION 48
1. Tear fluid cytokines and haze after PRK 48
2. Nerve regeneration after PRK 48
3. Corneal sensitivity after high myopic LASIK 50
4. Corneal sensitivity in primary Sjögren’s syndrome 52
5. Corneal nerves in primary Sjögren’s syndrome 53
SUMMARY AND CONCLUSIONS 57
ACKNOWLEDGMENTS 58
REFERENCES  60
ORIGINAL PUBLICATIONS 74
6LIST OF ORIGINAL PUBLICATIONS
This dissertation is based on the following original publications, which are referred to in the text
by Roman numerals I – IV:
I Ilpo S. J. Tuominen, Timo M. T. Tervo, Anna-Maija Teppo, Tuuli U. Valle, Carola
Grönhagen-Riska and Minna H. Vesaluoma. Human tear fluid PDGF-BB, TNF-?
and TGF- ?1 vs corneal haze and regeneration of corneal epithelium and subbbasal
nerve plexus after PRK. Exp. Eye Res. 2001;72:631–641.
II Ilpo S. Tuisku, Nina Lindbohm, Steven E. Wilson, Timo M. Tervo. Dry eye and
corneal sensitivity after high myopic LASIK. J. Refract. Surg. 2007;23:338-342.
III Ilpo S. J. Tuominen, Yrjö T. Konttinen, Minna H. Vesaluoma, Jukka A.O.
Moilanen, Maaret Helintö, Timo M. T. Tervo. Corneal innervation and morphology
in primary Sjögren’s syndrome. Invest. Ophthalmol. Vis. Sci. 2003;44:2545-2549.
IV Ilpo S. Tuisku, Yrjö T. Konttinen, Liisa M. Konttinen, Timo M. Tervo. Alterations
in corneal sensitivity and nerve morphology in patients with primary Sjögren’s
syndrome. Submitted 2007.
These publications have been reprinted with the kind permission of their copyright holders. In
addition, some unpublished material is presented.
7ABBREVIATIONS
APC Antigen-presenting cell
Ar-F Argon fluoride
ARVO Association for Research in Vision and Ophthalmology
BSCVA Best spectacle-corrected visual acuity
BM Basal membrane
BUT Tear break-up time
CCK Cholecystokinin
CGRP Calsitonin gene-related peptide
CMTF Confocal microscopy through focusing
D Diopter
DC Dendritic cell
DLK Diffuse lamellar keratitis
ECM Extracellular matrix
EGF Epidermal growth factor
Excimer Excited dimer
Fas Fas (Apo-95) receptor
Fas-L Fas-ligand
FML Fluorometholone
GAL Galanin
HGF Hepatinocyte growth factor
IGF Insulin-like growth factor
IL Interleukin
IVCM In vivo confocal microscopy
kDa kiloDalton
KGF Keratinocyte growth factor
LASIK Laser assisted in situ keratomileusis
LINE LASIK-induced neurotrophic epitheliopathy
M-ENK Methionine-enkephalin
NCE Noncontact esthesiometer
NFB Nerve fiber bundle
NGF Nerve growth factor
NPY Neuropeptide Y
OSDI Ocular surface disease index
PACAP Pituitary adenylate cyclase-activating polypeptide
PDGF Platelet-derived growth factor
PRK Photorefractive keratectomy
pSS Primary Sjögren’s syndrome
SP Substance P
SS Sjögren’s syndrome
sSS Secondary Sjögren’s syndrome
TGF-? Transforming growth factor - ?
TNF-? Tumor necrosis factor – ?
Trk Tyrosine kinase
TSCM Tandem scanning confocal microscopy
UCVA Uncorrected visual acuity
VAS Visual analog scale
VIP Vasoactive intestinal polypeptide
8
9ABSTRACT
This study aimed to investigate the morphology and function of corneal sensory nerves in 1)
patients after corneal refractive surgery and 2) patients with dry eye due to Sjögren’s syndrome.
A third aim was to explore the possible correlation between cytokines detected in tears and
development of post-PRK subepithelial haze. The main methods used were tear fluid ELISA
analysis, corneal in vivo confocal microscopy, and noncontact esthesiometry.
The results revealed that after PRK a positive correlation exists between the regeneration of
subbasal nerves and the thickness of regenerated epithelium.  Pre- or postoperative levels of the
tear fluid cytokines TGF-?1, TNF-?, or PDGF-BB did not correlate with the development of
corneal haze objectively estimated by in vivo confocal microscopy 3 months after PRK. After
high myopic LASIK, a discrepancy between subjective dry eye symptoms and objective signs
of dry eye was observed. The majority of patients reported ongoing dry eye symptoms even 5
years after LASIK, although no objective clinical signs of dry eye were apparent. In addition,
no difference in corneal sensitivity was observed between these patients and controls. Primary
Sjögren’s syndrome patients presented with corneal hypersensitivity, although their corneal
subbasal nerve density was normal. However, alterations in corneal nerve morphology (nerve
sprouting and thickened stromal nerves) and an increased number of antigen-presenting cells
among subbasal nerves were observed, implicating the presence of an ongoing inflammation.
Based on these results, the relationship between nerve regeneration and epithelial thickness 3
months after PRK appears to reflect the trophic effect of corneal nerves on epithelium. In
addition, measurement of tear fluid cytokines may not be suitable for screening patients for risk
of scar (haze) formation after PRK. Presumably, at least part of the symptoms of “LASIK-
associated dry eye” are derived from aberrantly regenerated and abnormally functioning corneal
nerves. Thus, they may represent a form of corneal neuropathy or “phantom pain” rather than
conventional dry eye. Corneal nerve alterations and inflammatory findings in Sjögren’s
syndrome offer an explanation for the corneal hypersensitivity or even chronic pain or
hyperalgesia often observed in these patients. In severe cases of disabling chronic pain in
patients with dry eye or after LASIK, when conventional therapeutic possibilities fail to offer
relief, consultation of a physician specialized in pain treatment is recommended.
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INTRODUCTION
The cornea is an avascular and delicate optically transparent tissue. Its transparency is
maintained by metabolically active pump systems located mainly in the endothelium.  Corneal
sensory nerves also have a crucial role in maintaining corneal architecture and transparency.
The cornea is one of the most densely innervated peripheral tissues in humans. Corneal nerves
interfere with epithelial mitotic activity and proliferation, and presumably also with the
regulation of keratocyte function. Secretion of tear fluid is also regulated by the corneal nerves
forming the afferent loop of the cornea-lacrimal gland reflex arc. Several systemic and corneal
disorders as well as ocular surgery may damage the corneal nerves and impair their function.
Consequently, the regulation of epithelial cell and keratocyte metabolism and also tear
formation and corneal sensitivity are disturbed until innervation is restored.
Corneal refractive surgery (PRK and LASIK) severs corneal sensory nerves, impairing corneal
sensitivity and function. Corneal nerve regeneration begins shortly, but the original fine nerve
architecture may never be completely restored. Patients experience varying degrees of dry eye
symptoms for a 1- to 6-month period following refractive surgery. Occasionally, extensive dry
eye symptoms or even ocular pain may persist for years, with or without dry eye signs. On the
other hand, patients may have clinical signs compatible with dry eye, but present with minimal
or no symptoms.
Dry eye is a common external eye disease that arises from a wide variety of etiologies.
Sjögren’s syndrome (SS) is a systemic autoinflammatory disorder of unknown etiology, and dry
eye is one of its major manifestations. Primary Sjögren’s syndrome (pSS) occurs without any
association with other rheumatological diseases. Consequently, it represents a relatively
homogeneous group of patients.
Patients presenting with symptoms compatible with dry eye, but with minimal or no dry eye
signs found on ocular examination are relatively frequently seen after refractive surgery. The
goal of this thesis was to explore the reasons behind this clinical discrepancy by investigating
corneal nerves and sensitivity in patients after refractive surgery and in patients with SS.
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REVIEW OF THE LITERATURE
1. Corneal structure
The cornea is an avascular tissue accounting for most of the refractive power of the human eye.
Due to its transparency, it allows light to enter the eye and to be projected to the retina.
According to a recent meta-analysis, the average thickness of the central cornea is 534 µm
centrally, although values are affected by measurement techniques: for slit-lamp-based optical
pachymetry, the mean central corneal thickness is 530 ?m, and for ultrasonic pachymetry 544
?m (Doughty and Zaman 2000). The normal cornea is thinnest in the center and thickest
peripherally, measuring approximately 650 ?m.
Anatomically, the cornea can be divided into five sublayers: 1. epithelium, 2. Bowman’s layer,
3. stroma or substantia propria, 4. Descemet’s membrane, and 5. endothelium.
The epithelium consists of 5-7 layers of nonkeratinized squamous epithelial cells, measuring
50–60 ?m in thickness. Three morphological cell types are present in human corneal
epithelium: superficial epithelial cells, intermediate wing cells, and the innermost basal
epithelial cells (Ehlers 1970). The corneal epithelium is a dynamic tissue in which cells are
constantly renewed and lost; nevertheless, the total mass is kept steady by mechanisms not yet
fully elucidated. A strong body of evidence suggests that corneal epithelial cells arise from
limbal stem cells (reviewed by Tseng 1989 and Dua et al. 2000). Once inside the cornea, cells
slowly move towards the apex in a centripetal fashion; this is supported by the XYZ theory by
Thoft and Friend (1983) as well as by various clinical observations (Bron 1973, Kaye 1980,
Lemp and Mathers 1989). Evidence for the XYZ theory has also been gained from in vivo
confocal microscopy studies (Auran et al. 1995) and experimental in vivo studies on transgenic
mice (Nagasaki and Zhao 2003).
Superficial epithelial cells, which form a barrier against foreign substances, are connected to
each other by tight junctions and desmosomes. They have numerous microvilli and microplicae
on their surfaces that increase the adherence of tear fluid mucins. The life span of surface
epithelial cells is only a few days, after which they are shed in tear fluid. The intermediate wing
cells form 2–3 layers beneath the surface epithelium and have wing-like extensions. The basal
epithelial cells form a monolayer of cells anchored tightly to the basement membrane with the
aid of hemidesmosomes and different anchoring fibrils (Gipson et al. 1989). Basal epithelial
cells have limited capacity to divide before terminal differentiation, thus being partly
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responsible for the excellent capability of the epithelium to regenerate (Hanna and O’Brien
1960, Kruse et al. 1990, reviewed by Li et al. 2007).
Bowman’s layer was first described by Sir William Bowman at the London Ophthalmic
Hospital (Moorfields) in 1847. Bowman’s layer separates the epithelium from the stroma,
acting as an anterior limiting membrane and giving tensile strength to the cornea. In Bowman’s
layer, individual collagen fibrils are interwoven densely to form a felt-like sheet. The thickness
of this acellular layer is 8 -12 ?m (Komai and Ushiki 1991).
The stroma, or substantia propria, consists of keratocytes, extracellular matrix, and nerve fibers.
The stroma constitutes the largest portion of the cornea; its thickness is approximately 470 ?m.
Three hundred to five hundred collagen lamellae running from limbus to limbus are oriented at
precise angles with respect to adjacent lamellae, contributing to corneal transparency and
strength (Komai and Ushiki 1991, reviewed by Ihanamäki et al. 2004). Stromal collagen
lamellae (consisting of types I, III, V, XII, and XIII) are surrounded by several proteoglycans
responsible for proper spacing of collagen and stromal hydration (reviewed by Ihanamäki et al.
2004).
Descemet’s membrane dividing the stroma from the endothelium acts as a basement membrane
for the endothelium. The thickness of Descemet’s membrane gradually increases from birth (3
µm) to adulthood (8-10 ?m) (Johnson et al. 1982).  The endothelium is a monolayer of 5-?m-
thick cells and is the innermost layer of the cornea, functioning in fluid pumping and regulation
of corneal hydration. Endothelial cells are not known to be capable of dividing, thus lacking
mitotic activity (Nishida 2005).
Figure 1. Schematic drawing of cornea: 1) epithelium, 2) subbasal nerve plexus and Bowman’s layer, 3)
stromal nerves, 4) stroma, and 5) Descemet’s membrane and endothelium.
1
2
3
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2. Corneal innervation and sensitivity
Corneal afferent sensory neurons are derived from the Gasserian ganglion and enter the eye ball
via long ciliary nerves, which are branches of the nasociliary portion of the ophthalmic division
of the trigeminal nerve. In some cases, the inferior cornea receives additional innervation from
the maxillary branch of the trigeminal nerve (Zander and Weddel 1951, Ruskell 1974, Rozsa
and Beuerman 1982).  Long ciliary nerves are myelinated until they penetrate the limbus and
form nerve bundles surrounded only by the Schwann’s cells (Zander and Weddel 1951). The
absence of myelin on central corneal axons is essential for maintaining corneal transparency. In
the human cornea, thick nerve trunks move from the periphery below the anterior third of the
stroma due to organization of collagen lamellae (Muller et al. 2001, Radner and Mallinger
2002). Nerve fibers run forward in a radial fashion towards the center of the cornea and
penetrate Bowman’s layer, then turning abruptly and continuing parallelly to the corneal
surface, simultaneously losing their Schwann’s cell ensheathment (Schimmelpfennig 1982,
Muller et al. 1996). Nerve fibers form a network by branching both vertically and horizontally
between Bowman’s layer and basal epithelial cells; this network is called the subbasal nerve
plexus (Muller et al. 1997). Nerve terminals are then sent between epithelial cells (Rozsa and
Beuerman 1982), electromicroscopic studies have shown evidence that nerve terminals
invaginate both basal epithelial cells and wing cells (Muller et al. 1996). Beaded nerve fibers,
with a diameter of approximately 2 µm, contain many mitochondria and glycogen, indicating
active metabolism, and are thought to also contain neuropeptides (Muller et al. 1996). Most of
the corneal neurons are classified as C-type, with a conducting velocity less than 2 m/s, and the
rest are myelinated A?-type axons, typically with conduction velocities between 2 and 15 m/s
(Belmonte and Tervo 2005).
Figure 2. After the stromal nerves have penetrated Bowman’s layer, they run parallel to the corneal
surface between the basal epithelium and Bowman’s layer, forming a neural network called the subbasal
plexus. 1) Wing cells 2) basal epithelial cells, and 3) Bowman’s layer.
2
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Several neural transmitters and neuropeptides have been demonstrated in the corneal nerves.
Substance P (SP) (Tervo et al. 1982), calcitonin gene-related peptide (CGRP) (Stone et al.
1986), and galanin (GAL) (Jones and Marfurt 1998) are of sensory origin. Catecholamines
(Toivanen et al. 1987) and neuropeptide Y (NPY) (Jones and Marfurt 1998) are of sympathetic
origin, and galanin (GAL) (Jones and Marfurt 1998), cholecystokinin (CCK) (Stone et al.
1984), vasoactive intestinal peptide (VIP) (Jones and Marfurt 1998), and methionine-enkephalin
(M-ENK) (Jones and Marfurt 1998) are of parasympathetic origin.
Development of modern corneal imaging techniques, such as in vivo confocal microscopy
(IVCM), has enabled corneal nerves in living corneas to be analyzed. IVCM allows
visualization of the subbasal nerve plexus, and is also used in imaging normal corneas
(Oliveira-Soto and Efron 2001, Grupcheva et al. 2002 and Patel et al. 2005), patients after PRK
(Heinz et al. 1996, Kauffmann et al. 1996, Linna and Tervo 1997, Bohnke et al. 1998, Frueh et
al. 1998, Moilanen et al. 2003, Erie et al. 2005b), patients after LASIK (Kauffmann et al. 1996,
Linna et al. 2000, Lee et al. 2002, Calvillo et al. 2004, Bragheeth and Dua 2005, Erie et al.
2005b), patients with herpetic keratitis (Rosenberg et al. 2002), patients with keratoconus (Patel
and McGhee 2006), patients with diabetes mellitus (Rosenberg et al. 2000b), and patients with
various corneal dystrophies, e.g. epithelial basement membrane dystrophy (Rosenberg et al
2000a), lattice dystrophy type II  (Rosenberg et al. 2001), cornea plana (Vesaluoma et al. 2000),
and Fuchs’ dystrophy (Mustonen et al. 1998).  Patel et al. (2005) have developed a novel
technique to elucidate the overall distribution of subbasal nerves in the human cornea by laser
scanning in vivo confocal microscopy. Multiple images are obtained from several locations in
the cornea, and overlapping images are later reconstructed to confluent montages. With the aid
of this novel technique, they observed that subbasal nerves were settled in a whorl-like pattern,
similar to that seen in the epithelium in corneal verticillata. On the basis of their observations,
they hypothesized that epithelial cells and nerves would migrate centripetally in tandem (Patel
et al. 2005).
Normal corneal sensitivity is higher in the center of the cornea than at the periphery (Millodot
and Larson 1969). Accordingly, the central cornea is 5-6 times more densely innervated than
the peripheral cornea (Muller et al. 1997). The cornea is one of the most densely innervated
peripheral tissues in humans; the nerve density is estimated to be 300–400 times higher than in,
for example, the human finger (Rozsa and Beurman 1982, reviewed by Muller et al. 2003).
Based on electrophysiological studies, different functional types of sensory nerve fibers exist in
the cornea. The majority of corneal nerves are polymodal nociceptors (70%), which are
activated by near-noxious mechanical energy, heat, chemical irritants, and a large variety of
endogenous chemical mediators. Mechano-nociceptors, accounting for 15-20% of corneal
peripheral axons, respond only to coarse mechanical forces in the order of magnitude close to
that required to damage corneal epithelial cells. Cold-sensitive thermal axons accounting for the
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remaining 10-15% of corneal peripheral axons, respond by increasing their firing rate when the
corneal temperature falls below normal levels (reviewed by Belmonte et al. 2004, Belmonte and
Tervo 2005). Several corneal diseases, corneal dystrophies, and ocular surgery may cause a
decline in corneal sensitivity (reviewed by Muller et al. 2003). In addition, corneal sensitivity
has been reported to diminish with increasing age (Millodot 1977), although the density and
orientation of the subbasal nerves seem to be unaffected (Erie et al. 2005a).
Corneal sensitivity can be tested in the clinical setting by gently touching the ocular surface
with a wisp of cotton and observing the blink reflex or by comparing the subjective sensation
with that evoked from the other eye. This information is easily obtained in clinical settings.
However, the results are not quantified and represent only an approximation of the functional
status of corneal nerves. The Cochet-Bonnet esthesiometer represents a more quantitative
approach and uses a calibrated nylon hair of variable length. It measures mainly coarse
mechanical sensation and cannot discriminate between mechanical, thermal and chemical
sensations. Moreover, it has a limited ability to accurately measure corneal sensitivity at low
stimulus thresholds compared with modern noncontact gas esthesiometers (Murphy et al. 1998).
The noncontact gas esthesiometer uses an air jet of adjustable flow and temperature that may
contain CO2 in a variable concentration to reduce local pH. This allows mechanical, thermal, or
chemical stimulation of a specific limited area of the cornea (Belmonte et al. 1999). The
noncontact gas esthesiometer is more accurate and has better repeatability than the Cochet-
Bonnet esthesiometer (Murphy et al. 1998).
3. Neurosecretorial regulation of tearing
Main lacrimal glands are innervated by parasympathetic and sympathetic nerves (Botelho et al.
1966, Sibony et al. 1988). In addition, scarce sensory nerves have been identified in lacrimal
glands (Botelho et al. 1966). Nerves are located in close proximity to acinar, ductal, and
myoepithelial cells as well as to blood vessels (Botelho et al. 1966, Sibony et al. 1988).
Stimulation of the lacrimal gland and secretion occur via the cornea – trigeminal nerve –
brainstem – facial nerve – lacrimal gland reflex arc. Afferent sensory nerves of the cornea and
conjunctiva are activated by stimuli to the ocular surface. Efferent parasympathetic and
sympathetic nerves are then activated to stimulate secretion from acinary and tubular cells
(Botelho 1964). Neurotransmitters and neuropeptides released by lacrimal gland nerves include
acetylcholine (Botelho 1964), vasoactive intestinal peptide (VIP) (Uddman et al. 1980),
neuropeptide Y (NPY) (Tsukahara and Jacobowitz 1987), substance P (Nikkinen et al. 1984),
and calcitonin gene-related peptide (CGRP) (Tsukahara and Jacobowitz 1987).
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While regulation of tearing is under tight neural control, a loss of innervation in the inflamed
lacrimal gland has been suggested to explain associated decreased secretory function in SS dry
eye (Hakala and Niemelä 2000). Accordingly, lymphocytic infiltration of lacrimal glands was
associated with decreased reflex tearing (Schirmer’s test II with nasal stimulation) in dry eye
(Tsubota et al. 1996).   However, several studies have shown that viable nerves do exist in
nonfibrotic areas of lacrimal glands, while they are absent in fibrotic areas (Zoukhri et al. 1998a
and Zoukhri et al. 1998b). Hence, the lack of lacrimal gland secretion in SS cannot be explained
by a loss of neural support. Zoukhri and Kublin (2001) found that remaining nerves were unable
to release their neurotransmitters and this also correlated with the lack of lacrimal gland protein
secretion. In conclusion, autonomic nerves in the lacrimal gland are not lost in SS dry eye, but
the inability to release their neurotransmitters seems to play an important role in impaired
lacrimal gland secretion.
4.           Tear fluid cytokines
Corneal cells are known to express different cytokines and/or their receptors potentially
modulating wound healing (Wilson et al. 1992, 1994a, 1994b, 1996a, Li and Tseng 1996).
The transforming growth factor (TGF) – ? family, consisting of TGF-b1, TGF-b2, and TGF-b3,
are polypeptides of approximately 25 kDa (Kokawa et al. 1996). TGF-? is generally thought to
inhibit epithelial, endothelial, and leukocyte cell growth and to stimulate proliferation of
fibroblasts (Song et al. 2002). TGF-b2 seems to be the major isoform present in all types of
corneal cells (Nishida et al. 1995), but TGF-b1 has also been detected in small amounts in all
corneal layers (Wilson et al. 1992, Nishida et al. 1995). In addition, TGF-b1 and 2 have been
shown to be present in human tear fluid (Gupta et al. 1996, Kokawa et al. 1996, Vesaluoma et
al. 1997a). TGF-b1 and 2 are produced and TGF-b1 secreted by the human lacrimal gland,
suggesting that the lacrimal gland may be one source of TGF-b in human tear fluid (Yoshino et
al. 1996). TGF- b 1 is involved in the regulation of keratocyte activation, myofibroblast
transformation, proliferation, chemotaxis, and wound healing after refractive surgery, and it is
strongly associated with excessive scarring (Jester et al. 1996, 1999, Andresen et al. 1997,
Myers et al. 1997, Andresen and Ehlers 1998, Moller-Pedersen et al. 1998b, Jester et al. 2003).
Platelet-derived growth factor (PDGF) is a cysteine knot-containing dimer of 35 kDa composed
of an A and B chain. It exists as isomers PDGF-AA, PDGF-AB, and PDGF-BB (reviewed by
Jones and Kazlauskas 2001). PDGF-BB is produced by corneal epithelial cells and is bound at
high levels in the epithelial basement membrane (reviewed by Wilson et al. 2001). PDGF
receptors are found in corneal fibroblasts (Li and Tseng 1996).  PDGF-BB has also been shown
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to have mitogenic, chemotactic, and migratory effects on corneal fibroblasts in vitro
(Hoppenreijs et al. 1993, Andresen et al. 1997, Andresen and Ehlers 1998, Kamiyama et al.
1998, Kim et al. 1999, Jester et al. 2002).
Tumor necrosis factor-a (TNF-a), on the other hand, is an inducer of apoptosis, which is
supposed to play an important role in the first steps of corneal wound healing after PRK
(Wilson et al. 1996a, 1996b, Helena et al. 1998). TGF-b1, TNF-a, and PDGF-BB are present in
low concentrations in human tear fluid, and PRK induces an increased release of TGF-b1, TNF-
a, and PDGF-BB during the early days of wound healing (Gupta et al. 1996, Vesaluoma et al.
1997a, 1997b, 1997c).
5. Corneal wound healing
Corneal wound healing is a complex physiologic sequence of events that contributes to re-
establishment of normal function and clarity of the cornea. Interindividual variations in the
wound healing process after all keratorefractive procedures are the major determinants of
surgical outcome. The wound healing process plays a critical role in overcorrection,
undercorrection, regression, and other complications as well as in corneal haze and refractive
instability. Major challenges of corneal refractive surgery are to control the wound healing
process more precisely and to promote more tissue regeneration than tissue fibrosis (Stramer et
al. 2003, reviewed by Fini and Stramer 2005).
Interaction between the corneal epithelium and stroma is a well-known phenomenon and a
critical step in corneal wound healing. Removal of the epithelium induces disturbances in ATP
content of anterior keratocytes (Herrman and Lebeau 1962), and the anterior stroma beneath the
epithelial wound becomes acellular within the following 24 h (Nakayasu 1988, Campos et al.
1994). Initially, the keratocyte loss was thought to be the result of mechanical trauma or
osmotic changes (Dohlman et al. 1968). However, more recently, the loss of keratocytes
following epithelial removal has been shown to be mediated primarily by apoptosis (Wilson et
al. 1996a, 1996b, Gao et al. 1997, Helena et al. 1998, Kim et al. 1999). Among others,
interleukin – 1? (IL-1?) and TNF-? are released from the injured corneal epithelium and induce
autocrine suicide in keratocytes by activating the Fas / Fas-ligand system (Wilson et al. 1996b,
Mohan et al. 1997, reviewed by Wilson et al. 2001).
After stromal keratocyte loss due to apoptosis, stromal cells adjacent to the wound area become
activated and proliferate. The activated keratocytes migrate to the wound area (Hanna et al.
1989, Del Pero et al. 1990, Zieske et al. 2001), and five days after wounding, these migrated
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keratocytes in the wound area undergo subsequent rounds of cell division and repopulate the
wound area (Zieske et al. 2001).
Table 1. Characteristic differences in activated keratocytes.
Fibroblasts
Myofibroblasts /
Altered keratocytes
Presence in epithelial abrasions + -
Presence in wounds penetrating Bowman’s layer + +
Association with wound fibrosis - +
Biomechanical activity less active active
Expression of ?-smooth muscle actin - +
Expression of collagens, fibronectin, and other matrix
proteins - +
Expression of MMPs upregulated downregulated
The extent of the initial wound, especially whether or not the epithelial basement membrane is
disrupted, results in different phenotypes of activated keratocytes: fibroblasts or myofibroblasts/
altered keratocytes (Table 1). Wounds that penetrate the basement membrane, such as
keratectomy, lead to the presence of myofibroblasts in the wound area, while after pure
epithelial abrasions with an intact basement membrane, myofibroblast are not present (Moller-
Pedersen et al. 1998b, Zieske et al. 2001). Fibroblasts are less biomechanically active,
synthesize matrix metalloproteinases (West-Mays et al. 1997, Bargagna-Mohan et al. 1999),
and are associated with corneal ulceration (Riley et al. 1995, Hargrave et al. 2002).
Myofibroblasts, by contrast, are associated with wound fibrosis, synthesize collagen,
fibronectin, and other matrix proteins (Ohji et al. 1993, Jester et al. 1996), and have
downregulated matrix metalloproteinase production (Girard et al. 1991, Fini et al. 1995, West-
Mays et al. 1999).  Myofibroblasts express ?-smooth muscle actin and have well-developed
focal adhesions, while fibroblasts do not express ?-smooth muscle actin and have poor focal
adhesions (Jester et al. 1995, 1996, Petridou et al. 2000). Myofibroblasts have strong
biomechanical involvement in matrix organization and wound contraction. Excess proliferation
of stromal fibroblasts and myofibroblasts results in stromal hyperplasia and clinical haze,
affecting optical transparency of the cornea (Moller-Pedersen et al. 1998a, 1998b). TGF-?
seems to be the most essential cytokine in orchestrating the transformation process of
myofibroblasts (Jester et al. 1997, 2003). However, in the cornea, the synergistic function of
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TGF-? and PDGF via integrin signaling pathways is needed for myofibroblast transformation
(Jester et al. 2002).
The epithelial healing process requires epithelial cell proliferation, migration, and
differentiation. The combination of cytokines and growth factors present in corneal cells and
tear fluid regulates the early epithelial wound healing cascades. Paracrine cytokine trafficking in
the human cornea presents a unique stromal / epithelial interaction (Wilson et al. 1994a).
Cytokines responsible for epithelial proliferation are keratinocyte growth factor (KGF),
hepatocyte growth factor (HGF), and epidermal growth factor (EGF) (Wilson et al. 1993,
1994b, 1994c, Tervo et al. 1997). Epithelial proliferation is further stimulated by increased
levels of PDGF-BB (Li and Tseng 1997). Elevated production of KGF and HGF by keratocytes
is present up to 7 days after corneal injury (Wilson et al. 1999a). In addition, increased reflex
tear fluid production results in higher availability of HGF (Tervo et al. 1997), PDGF-BB
(Vesaluoma et al. 1997c), and EGF (van Setten 1990). Enhanced expression of mRNA for EGF
and HGF is present in the lacrimal gland after wounding, contributing to greater availability in
tear fluid (Wilson et al. 1999b). In addition, mRNAs for EGF and HGF receptors are
concurrently upregulated in the epithelium and keratocytes (Wilson et al. 1999a).
Migration of epithelial cells at the wound periphery is induced by HGF (Li and Tseng 1997)
and EGF (Wilson et al. 1994c) on a provisional fibronectin matrix that accumulates around the
wound (Maldonado and Furcht 1995). Fibronectin is not present in the normal corneal epithelial
basement membrane, but 8 h after wound healing it is detected in the epithelium (Fujikawa et
al. 1984). Endogenously produced fibronectin by corneal epithelial cells promotes cell adhesion
(Ohji et al. 1993). Elevated levels of fibronectin are also found in human tear fluid after PRK,
promoting epithelial cell migration and attachment (Virtanen et al. 1995).
Once epithelial confluence is achieved, the epithelial cells are triggered to proliferate and
sequentially differentiate to form a normal corneal stratified epithelium (Wilson et al. 1994c).
Normal composition of the basement membrane is achieved by restoring collagens and
laminins, which occurs when the fibronectin matrix disappears (reviewed by Suzuki et al.
2003).
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6. Antigen-presenting cells
In 1867, Engelman noted dendritic or polygonal cells in the corneal epithelium. One year later,
a medical student Paul Langerhans observed dendritic cells in the skin epidermis. Similarities
between corneal dendritic cells and Langerhans cells of the skin have since been proposed. The
cornea is an immune privileged tissue and has long been considered to lack antigen-presenting
cells (APC) (Gillette et al. 1982). Today, APCs are known to play a critical role in corneal
immunology in both health and disease (Hamrah et al. 2002, Rosenberg et al. 2002, Hamrah et
al. 2003a, 2003b, Zhivov et al. 2005, 2007, Mastropasqua et al. 2006).
Two distinct phenotypic populations of APCs in the normal cornea have been reported.
Immature APCs, which do not express MHC class II antigen on their surface, tend to be located
in the central corneal epithelium. Immature APCs have a large cell body with only a few short
processes, if any (Hamrah et al. 2003a). These APCs are able to capture the antigen, but are
unable to present to lymphocytes. Mature APCs, by contrast, have a slender nucleated cell body
from which mazes of long membrane processes extend that resemble dendrites of nerve cells.
Mature APCs, expressing MHC class II antigen, are found in the peripheral corneal and limbal
epithelium (Hamrah et al. 2002, 2003a, 2003b).
The evolution of corneal in vivo imaging techniques has provided new data regarding human
corneal APCs in living tissue. The density of APCs declines from the limbus to the center of
healthy corneas (Hamrah et al. 2002, Zhivov et al. 2005, 2007, Mastropasqua et al. 2006). In the
corneal limbal epithelium, dendritic cells are found in virtually every healthy subject, while
only 20–30% of healthy controls show APCs in the central cornea (Zhivov et al. 2005, 2007,
Mastropasqua et al. 2006). More often APCs are present in the peripheral cornea, where they
show signs of a mature phenotype with long slender dendritic processes, whereas immature
APCs without dendrites typically predominate in the central cornea (Zhivov et al. 2005). Most
of the APCs are located at the level of subbasal cells or among the subbasal nerve plexus
(Zhivov et al. 2005).
7. Excimer laser
The excimer laser used to sculpt the cornea has been the single most important advancement in
the field of refractive surgery. Excimer laser keratectomy involves remodeling the corneal
stroma by tissue removal. The advantage of the excimer laser is its ability to remove tissue with
a microscopic precision unattainable with other procedures.
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Excited dimers are molecules with bound upper states and weakly bound ground states. The
reaction of an excited rare gas atom with a halogen atom produces excited dimers that emit
ultraviolet radiation when decaying from the bound upper state to the rapidly dissociating
ground state. Trokel et al. (1983) demonstrated that far-UV laser emissions (between 150 and
200 nm) can precisely remove corneal tissue without apparent thermal trauma to the adjacent
tissue. According to several experimental studies, the 193 nm UV light from the argon fluoride
laser was established as the optimal wavelength with the least corneal transmission. The high-
energy UV photons emitted by the  argon fluoride laser caused less adjacent thermal trauma and
created smoother ablation than longer wavelength lasers (Trokel et al. 1983).
8. Photorefractive keratectomy – PRK
Photorefractive keratectomy (PRK) is based on the use of excimer laser for accurate removal
and resculpturing of corneal tissue in order to change the corneal curvature and refractive power
of the cornea. Before excimer laser photoablation, the epithelium must be removed either
mechanically with a blunt spatula or brush, or by excimer laser (Trokel et al. 1983, Seiler and
Wollensak 1991, Palllikaris et al. 1994, Gimbel et al. 1995).
Figure 3. Myopic PRK. After the epithelium is removed either mechanically or by excimer laser,
Bowman’s layer, subbasal nerves, and the anterior stroma, including stromal nerves, are photoablated
by excimer laser. The depth of ablation depends on the magnitude of dioptric correction. Accordingly,
stromal nerves are destroyed to a variable extent depending on ablation depth.
Clinical studies have shown relatively good safety, predictability, and refractive results in low
to moderate myopia (Seiler and Wollensak 1991, Gartry et al. 1992, McDonald et al. 1999).
However, deeper ablation depths and higher corrections produce a greater incidence of
postoperative haze and regression and less predictable refractive results (Seiler et al. 1992, Shah
et al. 1998).
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8.1 Nerve regeneration after PRK
PRK photoablates Bowman’s layer, subbasal nerves, and anterior stromal nerves in the ablation
zone, leaving sharply cut nerve trunks at the base and margin of the wound (Tervo et al. 1994,
Trabucchi et al. 1994). The degree of stromal nerve destruction depends on the required
ablation depth. Considerable data exists on corneal nerve regeneration after PRK, including
both experimental and human studies done by in vivo confocal microscopy (IVCM).
Experimental studies using histochemical methods have shown that nerve regeneration after
PRK is a biphasic process (Rozsa et al. 1983, Beuerman and Rozsa 1984, Tervo et al. 1994). In
the first phase, the reinnervated subbasal plexus is formed by fine neurites that originate from
the cut peripheral nerve plexus and extend centrally alongside the migrating epithelial cells
(Rozsa et al. 1983, Beuerman and Rozsa 1984, Tervo et al. 1994). Neurofilament
immunoreactivity can be observed as early as 24 h after the procedure (Trabucchi et al. 1994).
The second phase of nerve regeneration is initiated by the degeneration of wound-oriented
neurites and the concomitant appearance of a second generation of stromal neurites that
ultimately re-establish a new subbasal plexus (Rozsa et al. 1983, Beuerman and Rozsa 1984).
The second-phase neurites originate from the transected stumps of stromal nerves at the wound
base and the wound margin (Rosza et al. 1983). The regenerating stromal nerves reach the
epithelium and contribute to the formation of a new subbasal plexus 6 months after PRK (Tervo
et al. 1994, Trabucchi et al. 1994). Trabucchi et al. (1994) observed a regenerated nerve plexus
at 1–4 months after surgery that actually appeared thicker than normal. Ishikawa et al. (1994)
noted a transient increase in intraepithelial nerves after PRK, the density returning to normal
levels by about 7 months after surgery. Normal density of intraepithelial nerve endings was
reached 3 months after PRK (Tervo et al. 1994). However, the morphological alterations in the
epithelial nerves persisted for as long as 12 months after the procedure, with stromal nerve
alterations also being present (Tervo et al. 1994).
In vivo confocal microscopy (IVCM) enables imaging of the living cornea, allowing
observation of the regeneration of subbasal nerves after PRK.  The first regenerating subbasal
nerves have been seen as early as one week after PRK (Linna and Tervo 1997). At one month
after PRK, subbasal nerves were observed in only 1 of 18 eyes (Frueh et al. 1998). Partial or in
some cases total recovery of subbasal nerves has been reported to occur at 8-12 months after
PRK (Corbett et al. 1996, Kauffman et al. 1996). However, even at 5 years after PRK, some
corneas do not achieve a normal pattern of subbasal nerve morphology, although the mean
subbasal nerve density does not differ from that of normal controls (Moilanen et al. 2003). In a
recent prospective longitudinal study, preoperative levels of nerve density were achieved 2
years after myopic PRK, and the levels remained stable during the 5-year follow-up (Erie et al.
2005b).
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8.2 Corneal sensitivity after PRK
The early postoperative decline in corneal sensitivity is followed by a relatively fast recovery of
sensation in the following 3 months, when preoperative levels also in the central cornea are
achieved (Perez-Santonja et al. 1999, Matsui et al. 2001, Kumano et al. 2003, Lee et al. 2005).
Interestingly, in some studies, no decrease in corneal sensitivity after PRK was observed during
the follow-up (Kumano et al. 2003), while in another study a time period of up to 12 months
after PRK was needed to achieve normal sensitivity levels (Nejima et al. 2005). PRK patients
are characterized by higher tear fluid NGF levels 3 months postoperatively. Higher NGF levels
correlated with faster recovery of corneal sensitivity (Lee et al. 2005). Loss of sensitivity after
PRK seems to be less severe than after LASIK, and the overall rate of recovery of sensitivity to
preoperative levels is faster after PRK than LASIK (Perez-Santonja et al. 1999, Matsui et al.
2001, Kumano et al. 2003, Lee et al. 2005, Nejima et al. 2005).
9. Laser in situ keratomileusis - LASIK
Ionnis Pallikaris was the first to describe laser in situ keratomileusis (LASIK) in 1990
(Pallikaris et al. 1990). A hinged corneal flap, consisting of the epithelium, the subbasal nerve
plexus, and the anterior stroma, is created with a microkeratome.  After the flap is lifted, corneal
sculpturing is performed on the exposed stromal bed, after which the corneal flap is replaced.
The flap adheres spontaneously to the stromal bed, with no suturing required.
Figure 4. Myopic LASIK. A hinged flap, consisting of the epithelium, Bowman’s layer, subbasal nerves,
and the anterior stroma, is created using a microkeratome. After the flap is lifted, the corneal stroma is
sculptured using excimer laser.
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LASIK is nowadays the most commonly performed procedure in refractive surgery and the first
choice for the correction of refractive errors in the majority of patients (Duffey and Leaming
2005). It is a relatively safe, predictable, and effective method for correcting low to moderately
high (up to –15 D) myopia, offering many advantages over other existing procedures such as
fast and painless recovery of vision, less regression, and less subepithelial haze (McDonald et
al. 2001, Solomon et al. 2002, Sugar et al. 2002). However, patients subjected to LASIK
surgery often report dry eye symptoms postoperatively, and tear fluid abnormalities are
frequently described (Battat et al. 2001, Hovanesian et al. 2001, Toda et al. 2001, Albietz et al.
2004a, De Paiva et al 2006, Shoja and Besharati 2007). These symptoms are the most common
adverse effects of LASIK, causing frustration for both patients and surgeons alike (Sugar et al.
2002). LASIK-associated dry eye is believed to be attributable to the severing of the afferent
corneal nerves during the flap formation. Subbasal nerve bundles and superficial stromal nerve
bundles in the flap interface are cut by the microkeratome, with only nerves entering the flap
through the hinge region being spared. Subsequent sculpturing of corneal stroma using excimer
laser severs stromal nerve fiber bundles (Linna et al. 1998, 2000, Lee et al. 2002, Brageeth and
Dua 2005, Erie et al. 2005b).
9.1 Nerve regeneration after LASIK
The regeneration of corneal nerves after LASIK has been investigated in experimental models
(Latvala et al. 1996, Linna et al. 1998, Fukiage et al. 2007, reviewed by Tervo and Moilanen
2003). Thin regenerating nerve fibers form connections with neighboring stromal nerve fibers
and penetrate the most anterior acellular stromal layer to send subbasal nerve fibers to form the
nerve terminals between epithelial cells. Regeneration of anterior stromal, subbasal, and
epithelial nerve fibers occurs approximately 3 months after LASIK, while deep stromal nerves
may show abnormal morphology even 5 months after the procedure (Latvala et al. 1996, Linna
et al. 1998). Topically administered neurotrophic factor pituitary adenylate cyclase-activating
polypeptide (PACAP) has accelerated neural regeneration after LASIK in an experimental
model (Fukiage et al. 2007). Accordingly, topical neurotrophic factors PACAP and NGF seem
to enhance the recovery of sensitivity after LASIK (Joo et al. 2004, Fukiage et al. 2007).
However, lower tear fluid NGF levels after LASIK compared with PRK in human have been
accompanied by slower recovery of sensation (Lee et al. 2005).
In vivo confocal microscopy studies have enabled imaging of the living human cornea in four
dimensions (x, y, z, and t [time]) and have produced abundant information on regeneration and
morphological changes in corneal nerves during the post-LASIK healing process (Kauffmann et
al. 1996, Slowik et al. 1996, Linna et al. 2000, Lee et al. 2002, Perez-Gomez and Efron 2003,
Avunduk et al. 2004, Calvillo et al. 2004, Bragheeth and Dua 2005, Erie et al. 2005b).
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Degeneration of cut subbasal nerves manifests during approximately one week after surgery, at
which time subbasal nerve density decreases by 90% (Linna et al. 2000, Lee et al. 2002,
Calvillo 2004, Erie et al. 2005b). Thereafter, a slow regenerative process occurs and
regenerating nerve fibers form connections with neighboring nerve fibers. Prospective studies
have shown that during the first year after LASIK, subbasal nerve fiber bundles gradually
regenerate, achieving numbers that nevertheless remain more than 50% lower than before
LASIK (Lee et al. 2002). Total recovery of the subbasal plexus, especially its morphology,
probably never occurs, and a significantly longer period of time than previously assumed seems
to be needed. Subbasal nerve density remained < 60% of preoperative levels at 3 years post-
LASIK (Calvillo et al. 2004), and nerve density near preoperative densities was not reached
until 5 years after LASIK (Erie et al. 2005b).
9.2 Corneal sensitivity after LASIK
An early loss of corneal sensitivity to coarse mechanical stimulation has been reported after
LASIK, followed by progressive recovery of sensitivity during the following postoperative
months. Corneal sensitivity seems to be at its lowest 1-2 weeks after LASIK, and by 6-12
months sensitivity has recovered to normal levels (Kim and Kim 1999, Perez-Santonja et al.
1999, Linna et al. 2000, Benitez del Castillo et al. 2001, Toda et al. 2001, Donnenfeld et al.
2003, 2004, Michaeli et al. 2004, Bragheeth and Dua 2005, Lee et al. 2005). Recovery periods
of over 12 months have also been reported (Nejima et al. 2005). By contrast, the return of near-
normal sensitivity levels by 3 weeks post-LASIK has also been described (Chuck et al. 2000).
Studies comparing the recovery of corneal sensitivity after PRK and LASIK have utilized the
Cochet-Bonnet esthesiometer, which measures coarse mechanical sensation, but has certain
limitations in sensitivity and reproducibility (Murphy et al. 1998). In any case, after LASIK, the
loss of sensitivity seems to be more intense and the time needed for recovery longer (Perez-
Santonja et al. 1999, Matsui et al. 2001, Kumano et al. 2003, Lee et al. 2005). Interestingly,
lower tear fluid NGF levels in humans after LASIK, compared with PRK, have been
accompanied by slower recovery of sensation. NGF is known to be a potent neurotrophic factor,
and thus, tear fluid NGF is suggested to play a role in recovery of sensitivity as well as in
regeneration of corneal nerves (Lee et al. 2005).
More recently, noncontact gas esthesiometers, which are more sensitive and reproducible than
mechanical esthesiometers, have been utilized in studies exploring the recovery of corneal
sensitivity after LASIK (De Paiva and Pflugpfelder 2004, Gallar et al. 2004, Stapleton et al.
2006). In contrast to studies utilizing mechanical esthesiometers, which report the greatest
decrease of sensitivity 1-2 weeks post-LASIK (Linna et al. 2000, Donnenfeld et al. 2004), in the
above study, corneas were observed to be hypersensitive at 1 week post-LASIK (Gallar et al.
2004). This was followed by a significant decrease in sensitivity to mechanical stimuli during 3-
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5 months after surgery.  Corneal sensitivity was close to normal values by 2 years post-LASIK
(Gallar et al. 2004). Patients without dry eye at 1-40 months after LASIK presented with
decreased corneal sensitivity, while patients with LASIK-associated dry eye showed corneal
hypersensitivity at 3-36 months (De Paiva and Pflugfelder 2004). Corneal hypersensitivity
observed in LASIK-associated dry eye patients was suggested to result from compromised
ocular surface barrier function and hypersensitivity to air jet (De Paiva and Pflugfelder 2004).
Several factors influencing the severity of the postoperative decrease in corneal sensitivity and
subsequent recovery have been suggested, including ablation depth, hinge orientation (superior
or nasal), hinge width, and flap thickness.
Deep ablations, thus greater corrections, result in a larger decrease in corneal sensitivity and a
longer recovery (Kim and Kim 1999, Nassaralla et al. 2003, Bragheeth and Dua 2005, Shoja
and Besharati 2007). Accordingly, ablation depth is a clear risk factor for developing dry eye
after LASIK (De Paiva et al. 2006, Shoja and Besharati 2007).
Depending on the microkeratome used in LASIK, the hinge is positioned either superiorly or
nasally. While long ciliary nerves run and penetrate the cornea at the 3 and 9 o’clock positions,
it has been suggested that flaps with a superior hinge cause more severe nerve damage than
those with a nasal hinge, which spares the medial nerve fibers. Seemingly in agreement with
this concept, eyes with a nasal hinge were found to have less dry eye symptoms (Donnenfeld et
al. 2003) and better corneal sensitivity than eyes with a superior hinge during a 6-month
postoperative period (Donnenfeld et al. 2003, Vroman et al. 2005, Nassaralla et al. 2005).
However, a prospective randomized clinical study found no difference in dry eye signs or
symptoms between patients treated with superiorly and those with nasally hinged flaps
(Ghoreishi et al. 2005).
The narrow hinge of the flap resulted in a more pronounced decline in corneal sensitivity and
more severe dry eye than flaps with a broader hinge (Donnenfeld et al. 2004). The thickness of
the flap has also been suggested to be an important factor in regaining corneal sensitivity; thin
flaps with a nasally placed hinge were related to more rapid recovery (Nassaralla et al. 2005).
In conclusion, corneal mechanical sensitivity, measured with a Cochet-Bonnet esthesiometer,
decreases during the first postoperative weeks, and regeneration of nerves coincides with the
recovery of sensitivity, with normal sensitivity levels typically being achieved 6-12 months
after LASIK. However, studies utilizing more sensitive noncontact gas esthesiometers suggest
that alterations in corneal sensitivity may persist for up to 24 months.
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10. Dry eye
A definition of dry eye was recently produced by the International Dry Eye WorkShop (DEWS
2007): “Dry eye is a multifactorial disease of tears and ocular surface that results in symptoms
of discomfort, visual disturbance, and tear film instability with potential damage to the ocular
surface. It is accompanied by increased osmolarity of the tear film and inflammation of the
ocular surface (Lemp et al. 2007).”
Large epidemiological studies have revealed the prevalence of dry eye at various ages range
from 5% to 34% (Smith et al. 2007). However, the definition of dry eye and the diagnostic tests
and criteria varied markedly between these studies, and thus, caution is advised in making direct
comparisons between the results.
Dry eye is classified into two etiopathogenic categories: 1) aqueous tear-deficient dry eye and
2) evaporative dry eye.
Aqueous tear-deficient dry eye is further divided into SS dry eye and non-SS dry eye. Non-SS
dry eye includes 1) primary lacrimal gland deficiencies, e.g. age-related dry eye; 2) secondary
lacrimal gland deficiencies such as conditions with lacrimal gland infiltration, e.g. sarcoidosis,
lymphoma, acquired immunodeficiency syndrome (AIDS), or graft versus host disease; 3)
conditions associated with obstruction of lacrimal gland ducts, e.g. trachoma, cicatrical
pemphigoid, erythema multiforme, and chemical and thermal burns; 4) conditions affecting
sensory innervation, e.g. herpes simplex keratitis, herpes zoster ophthalmicus, penetrating
keratoplasty, PRK, LASIK, diabetes mellitus, and topical anesthetic abuse, as well as
secretomotor innervation, e.g. damage to the VII cranial nerve and certain systemic medications
(Lemp et al. 2007).
Evaporative dry eye may be intrinsic, with regulation of evaporative loss from the tear film
being directly affected by, for instance, meibomian lipid deficiency, poor lid congruity, wide lid
aperture, and low blink rate. Extrinsic evaporative dry eye embraces those etiologies that
increase evaporation by their pathological effects on the ocular surface, including vitamin A
deficiency, topical drug preservatives, contact lens wear, and ocular surface disease, e.g. allergy
(Lemp et al. 2007).
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Figure 5. Lacrimal gland functional unit. Stimulation of the free nerve endings in the cornea generates
afferent nerve impulses that travel through the ophthalmic division of the trigeminal nerve to the
superior salivary nucleus in the pons. The nerves synapse and the signal is integrated with cortical and
other input in the pons. The efferent branch of the loop passes along the nervus intermedius to the
pterygopalatine ganglion. Postganglionic fibers then terminate in the main and accessory (Wolfring and
Krause) lacrimal glands. Increasing evidence suggests that nerve endings found around the Meibomian
glands and conjunctival Goblet cells travel along the same route (Stern et al. 2004).
In the normal situation, the ocular surface, interconnecting nerves, and lacrimal glands form a
functional unit (Fig. 5) that controls the major components of the tear film and responds to
environmental, endocrinological, and cortical influences. If any portion of this funtional unit is
compromised, lacrimal gland support to the ocular surface is impeded (Stern et al. 2004).
29
11. Dry eye after refractive surgery
All keratorefractive surgical procedures, including PRK and LASIK, cause morphological and
functional disturbances of corneal nerves.  Dry eye is one of the most common complications
after refractive surgery (Hong and Kim 1997, Sugar et al. 2002). It is mainly thought to be
attributable to the transection of afferent corneal nerves during the lamellar microkeratome cut
in LASIK, and additional damage caused by excimer laser photoablation. The ocular surface,
lacrimal glands, and interconnecting nerves form a functional unit (Stern et al. 2004), and
impairment of corneal nerves interrupts the cornea–trigeminal nerve–brain stem–facial nerve–
lacrimal gland reflex arc, influencing both reflex and basal tear production.
The diagnostic criteria and treatment strategies for dry eye vary widely among
ophthalmologists, and among cornea and dry eye specialists. Some clinicians consider clinical
signs more essential than symptoms. Conversely, other clinicians value symptoms more highly
as early evidence of ocular disease. On the other hand, little correlation exists between the
symptoms and clinical test results in dry eye patients (reviewed by Pflugfelder et al. 2000 and
Bron 2001, Dogru et al. 2005). The clinical signs of LASIK dry eye include evaluation of tear
film stability with application of fluorescein to the tear film to measure tear film break-up time
and positive vital staining of the ocular surface with lissamine green, fluorescein or rose bengal.
Schirmer’s test with or without anesthesia is considered an important parameter at least for use
in studies where statistical trends can be monitored. However, there is no consensus as to which
method is most useful or regarding diagnostic cut-offs (reviewed by Bron 2001). Symptoms can
be monitored using different validated questionnaires such as the ocular surface disease index
(OSDI) questionnaire (Schiffman et al. 2000). Punctate epithelial keratopathy detected with rose
bengal or fluorescein staining has been noted in 2-6% of eyes that have undergone LASIK
(reviewed by Ang et al. 2001, Wilson 2001), but symptoms of ocular dryness and irritation were
noted in approximately half of the LASIK patients (Hovanesian et al. 2001).
In addition to decreased reflex and basal tear production, impairment of corneal nerves may
lead to LASIK-induced neurotrophic epitheliopathy (LINE) (Wilson 2001, Wilson and
Ambrosio 2001), where punctate epithelial microerosions are present on the corneal surface.
However, LASIK patients who developed symptoms and signs of dry eye after the procedure
had no significant difference in tear production detected by Schirmer’s test with anesthesia from
patients with no symptoms or signs of dry eye at time-points from 1 month to 6 months after
surgery (Wilson 2001). Soreness of the eye to touch was observed at 6 months more often after
PRK than LASIK, affecting 26.8% and 6.7% of patients, respectively (Hovanesian et al. 2001).
This was suggested to be related to symptoms of recurrent erosions.
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Other issues potentially contributing to dry eye symptoms after LASIK include differences in
corneal curvature; while normal corneas show prolate profiles, i.e. steeper in the center, and
high conventional myopic LASIK produces oblate corneas. These changes in corneal curvature
may interfere with even tear distribution, but the mechanical rubbing due to the anatomical
change may also be causative. Moreover, patients who seek refractive surgery are often contact
lens intolerant and may have preclinical dry eye before surgery. In addition, mechanical trauma
caused by the microkeratome suction ring to limbal Goblet cells has been suggested to play a
role in LASIK-associated dry eye (Lenton and Albietz 1999). Diminished afferent input also
results in a decreased blinking rate, which appears to be involved in the pathogenesis of
LASIK-associated dry eye (Toda et al. 2001).
Risk factors for developing LASIK-associated dry eye are: female gender, dry eye before
surgery (Albietz et al. 2004a), depth of photoablation, and preoperative refractive error
(Nassaralla et al. 2003, Albietz et al. 2004a, De Paiva et al. 2006, Shoja and Besharati 2007).
LASIK dry eye has been reported to develop more often in patients of Asian origin than in
Caucasians (Albietz et al. 2005).
In addition to symptoms of dry eye, blurring of vision, and halos, dry eye has been associated
with regression of refractive result in PRK (Corbett et al. 1996), hyperopic LASIK (Albietz et
al. 2002), and myopic LASIK (Albietz et al. 2004b).
12. Sjögren’s syndrome
In 1928, Swedish ophthalmologist Henrik Sjögren (1899-1986) saw a patient complaining of
dry eyes, dryness of mouth, and pain in several joints. Henrik Sjögren was not the first to notice
the combination of xeroftalmia, xerostomia, and arthralgia.  French ophthalmologist Henri
Gougerot published similar observations a few years earlier, in 1926. In 1933, Henrik Sjögren
defended his doctoral thesis “Zur Kentniss der Keratoconjunctivitis Sicca”, where he carefully
described 19 patients with a combination of dry eyes and dry mouth. The eponym “Gougerot-
Sjögren disease” appeared in the literature in the 1930s, but a decade later this was shortened to
Sjögren’s disease, mainly because of Sjögren’s ongoing interest in the syndrome.
Sjögren’s syndrome (SS) is a chronic, generalized autoimmune disease. Dry eye and dry mouth
are its major clinical manifestations. In primary Sjögren’s syndrome (pSS), typical symptoms
occur in a pure form without an association with any other underlying autoimmune diseases.
Secondary Sjögren’s syndrome (sSS) is associated with other autoimmune diseases such as
rheumatoid arthritis or systemic lupus erythematosus (Fox et al. 2000, Fox and Stern 2002). In
addition to sicca syndrome, patients frequently suffer from visceral manifestations, including
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autoimmune thyreoiditis, atrophic gastritis, renal tubular glomerular nephritis, autoimmune
hepatitis, and interstitial cystitis.
12.1 Neurological manifestations in Sjögren’s syndrome
In 1933, Henrik Sjögren described a patient with trigeminal nerve involvement in his doctoral
thesis. Since then, the trigeminal nerve has been identified to be the most commonly affected
cranial nerve in SS (Kaltreider and Talal 1969, reviewed by Kaplan et al. 1990). The overall
prevalence of peripheral neuropathy, most commonly of the distal sensory symmetrical type,
ranges from 10% to 30% in pSS; fortunately, these neuropathies are often subclinical
(Gemignani et al. 1994, Olney 1998, Barendregt et al. 2001). In a Japanese study on pSS
patients, trigeminal neuropathy was observed in 50% (Tajima et al. 1997), while in a Finnish
study only 4% of patients were reported to have trigeminal neuropathy (Hietaharju et al. 1990).
Electrophysiological studies of the trigemino-facial and trigemino-trigeminal reflexes in
patients with trigeminal nerve involvement suggest lesions in the neurons of the Gasserian
ganglia rather than in the trigeminal axons (Valls–Sole et al. 1990). The pathophysiological
mechanisms are unknown, but may involve vasculitis (Melgren et al. 1989) or lymphocytic
inflammation of nerve cell ganglia (Griffin et al. 1990). Decreased corneal sensitivity in SS-
related dry eye has been observed with the aid of the Cochet-Bonnet esthesiometer (Xu et al.
1996).
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AIMS OF THE STUDY
The role of corneal innervation in dry eye following corneal refractive surgery and in Sjögren’s
syndrome-related dry eye was investigated. The following goals were set:
1.  To examine the role of tear fluid cytokines, regeneration of subbasal nerves, and
 subepithelial haze after PRK using IVCM (I).
2. To examine the recovery of corneal sensitivity using a novel noncontact
esthesiometer in patients who had undergone  correction of high myopia by LASIK
and to assess the relationship between dry eye symptoms and sensory recovery (II).
3. To examine the alterations in corneal nerve morphology in primary Sjögren’s
syndrome (III).
4. To examine the relationship between corneal nerve morphology and corneal
sensitivity in primary Sjögren’s syndrome patients (IV).
33
SUBJECTS AND METHODS
1. Subjects
These studies were carried out according to the tenets of the Declaration of Helsinki at Helsinki
University Eye Hospital. Research protocols were approved by the Ethics Review Committee of
Helsinki University Eye Hospital. All patients and controls were informed both orally and with
a written brochure about the studies. Informed consent was obtained from all participants.
Table 2. Demographic characteristics of subjects enrolled in studies I-IV.
Patients
n
Female
%
Patients
age
Controls
n
Female
%
Controls
age
I - PRK 20 80 30.7 ± 5.9 - - -
II - LASIK 20 70 34.0 ± 7.4 10 60 39.8 ± 10.4
III - pSS 10 90 50.1 ± 13.5 10 90 48.3 ± 14.5
IV - pSS 20 95 54.5 ± 7.0 10 90 50.2 ± 4.6
Data presented as mean ± SD.
1.1 PRK patients (I)
The study evaluated 20 eyes of 20 patients (16 females and 4 males, mean age 30.7 ± 5.9 years)
scheduled for myopic PRK. The spherical equivalent (SE) of the intended correction was -4.7 ±
1.5 D (range -2.75 D to -9.00 D). Astigmatic correction was performed on 12 patients. The
intended cylinder correction was -0.73 ± 0.27 D (range -0.50 to -1.50 D).
1.2 LASIK patients and controls (II)
The study evaluated 30 eyes of 30 subjects. Twenty eyes of 20 patients (14 females and 6
males, mean age 34.0 ± 7.4 years) who had undergone > 10 D myopic LASIK 2-5 years earlier
were included in the study, and 10 eyes of 10 healthy volunteers (6 females and 4 males, mean
age 39.8 ± 10.4 years) served as a control group. The mean follow-up time was 44.2 ± 11.3
months (range 23-58 months). A cohort of patients who met the inclusion criteria was selected
from the hospital database. These patients were sent an invitation to an additional follow-up
examination. The inclusion criteria were 1) high myopic correction (SE > 10D) with or without
34
astigmatic correction and 2) time interval of 2 years or more after the last LASIK surgery.
Exclusion criteria were 1) re-treatments, and 2) patients with a history of any other ophthalmic
surgical operations.  The first 20 consecutive volunteers were included in the study.
1.3 Primary Sjögren’s syndrome patients and controls (III and IV)
Study III evaluated 20 eyes of 20 subjects. Ten patients with pSS (9 females and 1 male, mean
age 50.1 ± 13.5 years) were recruited from the Department of Rheumatology, Helsinki
University Central Hospital, where they had been thoroughly examined by a rheumatologist.
Ten age- and sex-matched healthy controls (9 females and 1 male, mean age 48.3 ± 14.5 years)
served as a control group. The mean duration of dry eye symptoms was 16.3 ± 8.2 years, but the
average time elapsed from diagnosis was only 8.0 ± 4.6 years.
Study IV evaluated 30 eyes of 30 subjects. Twenty patients with pSS (19 females and 1 male,
mean age 54.5 ± 7.0 years) and ten age- and sex-matched healthy controls (9 females and 1
male, mean age 50.2 ± 4.6 years) participated. The mean duration of dry eye symptoms was
18.3 ± 10.0 years, and the average time interval between first symptoms and diagnosis was 10.3
± 10.3 years.
SS diagnosis in both studies (III and IV) was made according to American–European consensus
criteria (Vitali et al.  2002). The diagnosis was set when at least 4 of the 6 following criteria
were met, with either item 4 (histopathology) or item 6 (serology) being present. Diagnosis was
also set if any 3 of the 4 objective criteria were present (i.e. items 3, 4, 5, and 6).
1. Ocular symptoms (daily, persistent, troublesome dry eyes for more than 3 months and/or
recurrent sensation of sand or gravel in the eyes and/or use of tear substitutes more than 3 times
a day).
2. Oral symptoms (daily feeling of dry mouth for more than 3 months and/or recurrently or
persistently swollen salivary glands or the need to frequently drink liquids to aid swallowing of
dry food).
3. Ocular signs (Schirmer’s I test, performed without anesthesia [< 5 mm in 5 min] and/or Rose
bengal score or other ocular dye score [> 4 according to van Bijsterveld’s scoring system]).
4. Histopathology (focal lymphocytic sialadenitis in minor salivary glands).
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5. Salivary gland involvement (unstimulated whole salivary flow [< 1.5 ml in 15 min] and/or
parotid sialography showing the presence of diffuse sialectasias and/or salivary scintigraphy
showing delayed uptake, reduced concentration, and/or delayed excretion of tracer).
6. Autoantibodies (antibodies to Ro [SSA] and/or La [SSB]).
Patient were excluded if they had past head and neck radiation treatment, hepatitis C infection,
acquired immunodeficiency syndrome (AIDS), pre-existing lymphoma, sarcoidosis, graft versus
host disease, or if they used anticholinergic drugs.
2. Methods
2.1 Clinical examination
Ophthalmic examination
All patients were evaluated for uncorrected visual acuity (UCVA) and best spectacle-corrected
visual acuity (BSCVA) and manifest refractions and underwent tonometry, slit-lamp
examination, and dilated funduscopic examination.
Schirmer’s test
Schirmer’s test was performed using a Schirmer test strip (Clement Clarke International Ltd.,
Harlow, United Kingdom). Two drops of oxybuprocaine hydrochloride 4 mg/ml (Oftan®
Obucain, Santen Oy, Tampere, Finland) were then administered to prevent reflex tearing. The
strip was positioned at the intersection of the temporal third with the nasal two-thirds of the
lower eyelid, and the patient waited for 5 min with eyes closed until the strips were removed,
and the length of the moistened area was measured.
Tear break-up time (BUT)
To measure BUT, 1 drop of oxybuprocaine hydrochloride 3 mg/ml and sodium fluorescein dye
1.25 mg/ml (Oftan® Flurecain, Santen Oy, Tampere, Finland) was instilled in the lower
conjunctival sac with a micropipette. The tear film was observed under cobalt-blue-filtered
light. The interval between the last complete blink and the first appearance of randomly
distributed dry spots was measured. The average of three measurements was calculated.
Grading of corneal fluorescein staining
Grading of corneal fluorescein staining was performed as recommended by Lemp (1995). The
cornea was divided into five areas: central, upper, temporal, inferior, and nasal. Punctate
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corneal staining was recorded using a standardized grading system of 0-3 for each of the five
areas, resulting in a scale of 0-15.
Clinical haze grading
Clinical corneal haze was estimated with a slit lamp according to the Fantes’ scale (Fantes et al.
1990). Criteria for corneal opacity grading were as follows: grade 0, totally clear; grade 0.5, a
trace or a faint corneal haze; grade 1, haze of minimal density seen with difficulty with direct
and diffuse illumination; grade 2, mild haze easily visible with direct focal slit illumination;
grade 3, moderately dense opacity partially obscuring the iris details; and grade 4, severely
dense opacity completely obscuring details of intraocular structures.
CMTF haze estimate
Confocal microscopy through focusing (CMTF) scans were obtained as previously described (Li
et al. 1997, Moller-Pedersen et al. 1997). Using the custom software, the CMTF data were
digitized onto the PC, intensity profile curves were calculated, and a quantitative estimate of the
increased back-scattering from the subepithelial haze (CMTF-haze estimate) was achieved. The
thickness of the haze area was also calculated. One to four acceptable CMTF scans were
produced for each eye. Mean values of the measurements were used for all statistical calculations.
Subjective dry eye symptoms
Subjective symptoms were evaluated using ocular surface disease index (OSDI), which is a
reliable and validated 12-item questionnaire for assessing subjective symptoms in ocular surface
diseases and the impact on visual functioning (Schiffmann et al. 2000). In addition, visual
analog scale (VAS) was used to evaluate global severity of ocular discomfort. The subjects
were asked to evaluate severity of ocular symptoms during the past month and to place a mark
with a pencil on a 100-mm scale, with the left end representing minimal symptoms (0 mm) and
right end maximal symptoms (100 mm).
2.2 Tear fluid analysis (I)
Tear fluid collection
All tear fluid samples were collected with a scaled 5- or 25-µl fire-polished microcapillary tube as
described previously (van Setten et al. 1989). Tears were collected preoperatively (day 0), on the
second postoperative day (day 2) and 3 months postoperatively. The samples were immediately
transferred to Eppendorf tubes and stored at -70oC until assessed. Tear fluid flow in the collection
capillary (µl/min) was calculated by dividing the volume of the tear fluid sample by the tear fluid
collection time. The tear flow-corrected concentration, i.e. rate of release, was calculated by
multiplying the concentration in the sample (ng/l) by the tear fluid flow in the collection capillary
(µl/min) (Vesaluoma et al. 1997a). As the interindividual variations in the tear fluid cytokine
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concentrations were high, changes (%) in the cytokine concentrations and rates of release in
preoperative vs. postoperative samples were also calculated.
Cytokine immunoassays
The concentrations of TGF-?1 in tear fluid were measured by an enzyme immunoassay
(Vesaluoma et al. 1997a). Microtiter plates (Maxisorp, Nunc Intermed, Denmark) were coated with
monoclonal mouse anti-TGF-b1, -b2, and -b3 (Genzyme Diagnostics, Cambridge, MA, USA) 0.1
µg/well in 0.05 M Na2CO3 buffer, pH 9.2, overnight at 4°C. After washing the wells with 0.05 M
phosphate-buffered saline, pH 7.3, containing 0.05% Tween 20, 100 µl of acid-activated and
neutralized (0.1 M HCL, 4°C, 1 h) standard dilutions (natural human TGF-b1, Code BDP 1, R &
D Systems, London, UK) and samples (final dilutions 18-fold) were added  to the wells and
incubated overnight at 4°C. The unbound material was removed with the above washing buffer,
and 100 µl of 1000-fold diluted antibodies to human TGF-b1 (Code 27.283.29, Jansen Biochimica,
Beerse, Belgium) conjugated with alkaline phosphatase was added and incubated at 37°C for 2 h.
After washing, the amount of alkaline phosphatase fixed to the tubes was determined in
diethanolamine (1.0 mol/l)-magnesium chloride (0.5 mol/l) buffer, pH 10.0, using p-nitro-
phenylphosphate as a substrate for 1 h at room temperature. The absorbance of the p-
nitrophenolate liberated was measured at 405 nm with a 340 ATC microtitration plate reader (SLT,
Lab-instruments, Vienna, Austria). The detection limit for the assay was 5 ng/l.
PDGF-BB concentrations were measured by a sandwich enzyme immunoassay (Vesaluoma et al.
1997b). Microtiter plates (MaxisorpTM, Nunc Instrumed, Denmark) were coated with goat IgG-
type antibody to highly purified Escherichia coli-derived recombinant human PDGF-BB (Code
AB-220-Na, R & D Systems Europe Ltd., Abingdon, UK) (0.25 µg/well) in 0.05 M Na2CO3
buffer, pH 9.2, overnight at 4°C. After washing the wells with 350 µl of water, 100 µl of
recombinant human PDGF-BB homodimer (Code 2038-01, Genzyme Diagnostics, Cambridge,
MA, USA) as a standard (serial dilutions from 1000 to 5 ng/l) or 5- to 20-fold diluted tears were
added to the wells and incubated at 24°C for 60 min on a horizontal rotating table (80 rpm). The
unbound material was removed and the wells were washed twice with saline containing 0.05%
Tween 20. One hundred microliters of 100-fold diluted rabbit antibody to human PDGF-BB (Code
ZP-215, Genzyme Diagnostics, Cambridge, MA, USA) was added and incubated for 1 h at room
temperature as above. After washing, 100 µl of 500-fold diluted alkaline phosphatase conjugated
swine antibody to rabbit IgG (Code 67850, Orion Diagnostica, Espoo, Finland) was added and
incubated as above. The plates were then washed three times with 350 µl of washing solution. The
amount of alkaline phosphatase fixed to the tubes was determined in 1.0 M diethanolamine-0.5 M
MgCl2 buffer, pH 10.0 (Code 170057, Reagena Ltd., Kuopio, Finland) at room temperature for 3 h
in the dark, using p-nitrophenolphosphate (Code 104-105, Sigma Chemical Co., St. Louis, MO,
USA) as a substrate. The absorbance of p-nitrophenolate liberated was measured at 405 nm with a
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340 ATC microtitration plate reader (SLT-Lab Instruments, Vienna, Austria). The absorbance of
the 0 ng/l standard was subtracted from all the other absorbances, and the delta absorbances were
used for calculations. The detection limit of the assay was 20 ng/l.
TNF-a concentrations were determined by a double antibody radioimmunoassay developed for
measuring of serum TNF as described by Vesaluoma et al. (1997b). A volume of 10 µl of tear fluid
samples was first diluted by adding assay buffer to reach a final volume of 100 µl. TNF-a from
tears competed with a fixed amount of 125 I-labeled TNF-a (10 000 counts/min for 50 µl) for the
binding sites of 30 000-fold diluted specific rabbit antibodies. The bound TNF-a was precipitated
with Sepharose-bound antirabbit IgG and centrifuged, and the radioactivity of the pellets was then
counted. E. coli-derived recombinant human TNF- a  (Code TNF-H, Genzyme Diagnostics,
Cambridge, MA, USA) was used as a standard. This had a molecular weight of 36 kDa, and a
specific activity > 1 x 107 U/mg of protein, as measured by bioassay with mouse L 929 cells.
Rabbit antiserum to human TNF-a (Code P-300A, Endogen, MA, USA) showed < 1% cross-
reaction with lymphotoxins. The detection limit of the assay was 10 ng/l.
2.3 In vivo confocal microscopy – IVCM (I, III, and IV)
Tandem scanning in vivo confocal microscopy (I and III)
A tandem scanning confocal microscope (TSCM, Model 165A, Tandem Scanning Corp., Reston,
VA, USA) was used to examine the central cornea. A 24X, 0.6 NA variable working distance
objective lens was used. The field-of-view with this lens is 450 x 360 µm, and the z-axis
resolution 9 µm. Images were detected by using a low-light-level camera (model VE1000; Dage-
MTI, Michigan, IN, USA) and recorded on SVHS tape. Video images of interest were digitized
using a PC-based imaging system with custom software (University of Texas, Southwestern
Medical Center at Dallas, Dallas, TX, USA).
In addition, confocal microscopy through focusing (CMTF) scans were obtained. Intensity profile
curves for digitized CMTF data were calculated. From each CMTF scan, epithelial, Bowman’s
layer, and total corneal thicknesses were measured.  The mean values of each individual’s
measurements were used for the statistical analysis.
After the layers of the central cornea had been scanned with the confocal microscope, special
attention was paid to the morphology of the surface and basal epithelium. The microscope was
then focused beneath the basal epithelium to evaluate the subbasal nerve plexus in detail.
Afterwards, images were digitized from the SVHS video tape, and the number of nerve fibers in
the image was determined using point-counting principles. The number of nerve fibers in the
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image with the most subbasal nerve fibers was used as a measure of nerve density. Nerve
morphology was assessed from the SVHS video tape and digitized images. The morphology of
the nerve fibers was evaluated, with attention being paid to the following aspects: thickness
(fine and faint, normal, thick), beading, side-branching, and sprouting. It must, however, be
noted that resolution of confocal microscopy enables counting of nerve fiber bundles, but not of
single fibers or terminals.
Scanning slit in vivo confocal microscopy (ConfoScan 3) (IV)
Corneal in vivo morphology was evaluated using an in vivo scanning slit confocal microscope
(ConfoScan 3, software version 3.4, Nidek Technologies Slr, Vigonza, Italy) equipped with a
Achroplan 40 x objective (Carl Zeiss Meditec AG, Jena, Germany).  A topical anesthetic was
instilled in the lower conjunctival fornix of both eyes before examination (oxybuprocaine
hydrochloride 4 mg/ml, Oftan® Obucain, Santen Oy, Tampere, Finland). The subject was
comfortably seated in front of the microscope with the aid of chin and forehead rests and asked
to look straight ahead, while a fixation target was not available. A drop of ophthalmic lubricant
gel (2 mg/g carbomere, Viscotears®, CIBA Vision Europe Ltd., Southhampton, UK) was
applied on the objective tip to serve as a coupling media. The microscope is supplied with
automatic alignment software that was used to center the objective.  Automated mode was used
to obtain full-thickness scans from the central cornea. During a scan, the instrument recorded
images at 25 frames/s as the focal plane advanced anteriorly 4.0-8.0 µm between frames; scans
were repeated until 350 frames were recorded.  The best focused confocal microscopic images
from the central cornea were used for nerve density calculations with software supplied by the
manufacturer. The field size of the microscope was 422 µm × 322 µm (0.136 mm2) based on
calculations from a calibration slide.
2.4 Noncontact esthesiometry (II)
Central corneal mechanical sensitivity was assessed with a modified Belmonte Noncontact
esthesiometer developed by the Cooperative Research Center for Eye Research and
Technology, Sydney, Australia, and based on an instrument previously designed by Dr. Carlos
Belmonte, which has been used extensively to assess corneal sensation in animals and humans
(Belmonte et al. 1999, Acosta et al. 2001). The instrument is mounted on the frame of an air
tonometer and has a box controller and two gas tanks, containing 100% air and 100% CO2,
respectively. The tip of the esthesiometer is adjusted to a distance of 4 mm in front of the
cornea, using a focusing mechanism.
Subjects were seated in front of the gas esthesiometer, with their chin placed in a cup and their
forehead against a band. An audible click produced by the opening of the gas valve identified
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the onset of the stimulus. After each pulse, the subject was asked to report whether the stimulus
was felt independently of the sensation evoked. Sequential stimulus was only performed after
the patient reported no sensation from the previous stimulation. Subjects were told to blink
freely between stimuli.
Mechanical stimulation consisted of a series of pulses of warmed air (constant temperature of
42°C at the tip of the probe), with flow varying from 0 to 160 ml/min, applied to the central
corneal surface. Sensation caused by the mechanical stimulation was determined using the
visual analog scale. Briefly, a series of 2-s pulses were applied randomly in 20 ml/min steps,
from 160 ml/min to 20 ml/min. After a negative answer, the next stimulus was 10 ml/min
higher until the lowest positive value was achieved. The lowest airflow that elicited a response,
even weakly, was recorded as the mechanical threshold.
2.5 PRK (I)
PRK was performed after surgical abrasion of the epithelium (diameter 6.5 mm) using a Beaver
Eye Blade (Becton Dickinson, Franklin Lakes, NJ, USA). Six-millimeter-wide PRKs of varying
ablation depths were performed using a VisX 20/20 excimer laser (VisX Co., Sunnyvale, CA,
USA) or a NIDEK EC 5000 excimer laser (Nidek, Gamagoni, Aichi, Japan). The mean ablation
depth was 60.7 ± 14.1 µm (range 36-93 µm).
Eye-patching and postoperative medication
Each eye was pressure-patched for 3 days following PRK. In the morning of the first and/or second
postoperative day, the patch was removed and the lids were gently cleaned with a paper wipe.
After waiting for about 30 s, the tear fluid sample was collected, after which chloramphenicol
ointment (Oftan Chlora; Santen, Tampere, Finland) was applied and the eye repatched. In addition
to the ointment twice a day for 4 days, the postoperative medication included fluorometholone
drops (Liquifilm-FML; Allergan, Irvine, CA, USA) starting on the fourth postoperative day three
times a day for 1-3 months, oral diclofenac sodium 25 mg (Voltaren; Ciba-Geigy, Basel,
Switzerland) 30 min before the operation and 2-3 times a day for the first days after PRK, and oral
diazepam 5-10 mg (Diapam; Orion, Helsinki, Finland) for the first two postoperative nights.
2.6 LASIK (II)
The corneal flap was created with an automated Hansatome microkeratome (Hansatome, model
HT 230, Chiron Vision, Hansa Research & Developement, Inc., Miami, FL, USA). The
intended thickness of the flap was either 160 or 180 µm, with a superiorly located hinge.
Subsequent laser ablation was performed using a VisX Star S2 (VisX Co., Sunnyvale, CA,
USA) excimer laser. The patients were prescribed topical ofloxacin 3 mg/ml (ExocinÒ; Allergan
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Pharmaceuticals Ltd., Westport, Ireland) three times a day for 7 days and fluorometholone 1
mg/ml, (Liquifilm-FMLÒ, Allergan Pharmaceuticals Ltd., Westport, Ireland) two times a day
for 7 days starting on day 2.  Nonpreserved artificial tears were to be used four times a day for
at least 6 months after the operation.
2.7 Statistical analyses
Statistical comparisons of the mean between groups were performed either with the t-test or
with the Mann–Whitney U-test for normally distributed or skewed data, respectively, using
SPSS for Windows (version 8.0 -11.0, SPSS Inc., Chicago, IL, USA). Normality of the data was
tested using the Shaphiro-Wilk test or the Kolmogorov-Smirnov test as appropriate. In addition,
histograms were used to help in testing normality of samples. Bonferroni corrections were
applied in multivariate analysis. Bivariate correlations were examined using Pearson’s (r) or
Spearman’s (rho) correlation test. All values are given as mean + standard deviation (SD) or
median and interquartile range (IQR) for normally distributed or skewed data, respectively. P-
values of less than 0.05 were considered statistically significant.
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RESULTS
1. Tear fluid cytokines, haze, and nerve regeneration after PRK (I)
1.1 Tear fluid cytokines after PRK
The tear fluid flow in the collection capillary was (mean ± SD) 9.6 ± 11.1 µl/min (0.7-42.9
µl/min) preoperatively, 43.0 ± 30.7 µl/min (7.1-125.0 µl/min; P < 0.001) on day 2, and 8.8 ±
8.2 µl/min (0.7-33.3 µl/min; P = 0.003) at 3 months postoperatively. A weak positive
correlation (r = 0.498, P = 0.03) was observed between ablation depth and tear fluid flow on
day 2. However, at 3 months postoperatively, no correlation existed between these parameters
(rho = -0.285, P = 0.237). Cytokine concentrations and rates of release are given in Table 3.
1. 2 IVCM three months after PRK
Confocal images can be found in the original articles (I, III, and IV) at the end of this thesis.
Surface epithelial cells, posterior stromal keratocytes, and endothelial cells of all corneas
presented with a normal shape and reflectivity (images not shown). The basal epithelial cell area
of two corneas showed pathological findings. The basal epithelial cells of a cornea with a
history of recurrent erosions presented with presumably intracellular deposits (Rosenberg et al.
2000). Similar deposits could be discerned among subepithelial haze resulting from highly
reflective keratocyte nuclei and visible keratocyte processes (I / Fig. 1A). Another cornea
showed highly reflective particles, round to oval in shape, in the subepithelial area (I / Fig. 1B).
The basal epithelial cells of all other patients appeared normal, and the Bowman’s layer was
absent in all corneas. The epithelial thickness varied from 25 to 49 µm (39 ± 7 µm), thus, the
epithelium was thinner than in normal corneas (Li et al. 1997).
The subbasal nerve plexus was absent in two corneas, and 18 corneas showed 1-5 (2.1 ± 1.4)
regenerating nerve fiber bundles (I / Fig. 1C). Subepithelial haze was observed in all corneas,
and in two cases it was very highly reflecting and appeared vacuolized (I / Fig. 1D). The first
anterior keratocytes exhibited brightly reflecting nuclei and thickened keratocyte processes as
signs of ongoing keratocyte activation (I / Fig. 1D). In one of these two corneas, the subbasal
nerve plexus was absent (I / Fig. 1D). In the other 18 corneas, haze was more subtle, and
subbasal nerve fiber bundles were visible (I / Fig. 1C), except in one case.  The mean CMTF
haze estimate was 506 ± 402 U, and the thickness of the haze area was 40.9 ± 9.2 µm. With the
slit-lamp, haze was mild (0.38 ± 0.39; range 0 – 1, (scale +0 to +4)) in all eyes. In general, the
CMTF haze estimates were relatively low, in accordance with the clinical scoring.
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Table 3. Concentrations and releases of PDGF-BB, TGF-?1, and TNF-? after PRK (I).
Release
 Day 0
Concentration
 Day 0
Concentration
Day 2
Concentration
Month 3
Release
Day 2
Release
Month 3
(ng /l) (ng/l) (ng/l) (pg/min) (pg/min) (pg/min)
PDGF-BB
Below detection
limit (n)
(13/19) (7/19) (10/20) (13/19) (7/19) (10/19)
Median 20 1230 660 0.02 51 2
Mean 1700 7280 2920 13 301 7
SD 4330 13500 5900 41 553 14
Min 20 20 20 0.02 0.02 0.02
Max 17780 56950 21200 180 2373 59
P-value 0.075 0.248 0.008* 0.721
TGF- ?1
Below detection
limit (n)
(12/19) (13/19) (7/20) (12/19) (13/19) (7/19)
Median 5 5 255 0.005 0.005 1
Mean 820 210 840 1 5 3
SD 2850 440 1500 2 10 4
Min 5 5 5 0.005 0.005 0.005
Max 12560 1720 6730 10 36 17
P-value 0.445 0.198 0.203 0.116
TNF-?
Below detection
limit (n)
(0/19) (0/19) (0/20) (0/19) (0/19) (0/19)
Median 1760 920 770 7 27 4
Mean 1920 1020 990 10 37 5
SD 1560 480 970 8 27 5
Min 120 240 90 2 11 0,8
Max 6910 1930 4150 30 120 18
P-value 0.039* 0.002* 0.000** 0.085
    * = P < 0.05, ** = P < 0.01
44
1.3 Correlations between IVCM data and cytokines (I)
The number of subbasal nerve fiber bundles was positively correlated with epithelial thickness
(r = 0.58, P = 0.007). However, the number of subbasal nerve fiber bundles was not correlated
with the CMTF haze estimate (rho = -0.281, P = 0.230) or the thickness of the haze area (r = -
0.398, P = 0.082). Ablation depth showed no correlation with nerve count (r = 0.240, P =
0.308), CMTF haze estimate (rho = 0.041, P = 0.865), or thickness of the haze area (r = -0.006,
P = 0.979). The CMTF haze estimate, as expected, showed a strong correlation with the
thickness of the haze area (rho = 0.783, P = 0.000).
No correlations were found between cytokine concentrations or rates of release at any time-
points and the CMTF haze estimate at 3 months. The magnitude of the changes from day 0 to
day 2 in the concentrations or rates of release of the three cytokines was not correlated with the
CMTF haze estimate at 3 months (data not shown).
2. Dry eye and corneal sensitivity after high myopic LASIK (II)
2.1 Subjective symptoms
The majority of patients (55%) reported dry eye symptoms when asked a simple question: Do
you have dry eyes?  Ocular surface disease index (OSDI) score, indicating degree of dry eye
symptoms, was significantly higher in LASIK patients (18.6 ± 6.4%) than in normal controls
(7.5 ± 5.7%; P = 0.022). However, almost all LASIK patients (95%) were satisfied with the
overall outcome and would have chosen the operation again. The only patient who was not
entirely satisfied had undergone epithelial erosion during the surgery and subsequent diffuse
lamellar keratitis (DLK) in both eyes. A predisposing factor seemed to be a loose epithelium
due to basement membrane dystrophy, although the patient had a negative history of erosions
and the preoperative examination revealed no abnormalities.
2.2 Objective dry eye tests
We found no difference in objective dry eye tests. Schirmer’s test values did not differ
significantly between patients and controls (14.4 ± 8.9 mm and 9.0 ± 4.2 mm, respectively, P =
0.066), although LASIK patients showed slightly higher scores contrary to expectations. Tear
BUTs were similar in patients and controls (15.9 ± 11.2 s and 14.0 ± 10.0 s, respectively, P =
0.505). None of the patients or controls showed corneal fluorescein staining.
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2.3 Corneal sensitivity
The mean corneal sensitivity thresholds did not differ between the groups, being 73.5 ± 29.6
ml/min in LASIK patients and 78.0 ± 18.7 ml/min in controls (P = 0.666). No correlations were
present between corneal sensitivity threshold values and OSDI scores. Even when patients were
divided into two groups: 1) patients claiming to have dry eyes and 2) patients claiming not to
have dry eyes, we found no significant difference between sensitivity threshold values. No
significant correlation existed between corneal sensitivity thresholds and objective dry eye signs
(Schirmer’s test or BUT).
3. Corneal morphology and sensitivity in primary Sjögren’s syndrome
               (III and IV)
3.1 Subjective symptoms (IV)
OSDI and VAS scores were significantly higher in pSS patients than in controls (Table 5), with
a strong positive correlation between these two measures of ocular discomfort (rho 0.92, P <
0.01), suggesting that VAS can be used to assess severity of dry eye symptoms in a relatively
time-effective manner.
3.2 Objective dry eye tests (III and IV)
Objective dry eye test values (Schirmer’s test, tBUT) were lower in pSS patients than in
controls (Tables 4 and 5). Corneal fluorescein was observed in the majority of pSS patients,
while none of the controls showed corneal fluorescein staining (Tables 4 and 5).
Table 4. Characteristics of pSS patients and controls (III).
pSS Controls P-value
Number of patients 10 10 -
Nerve count (nerves/frame) 5.4 ± 1.8 5.0 ± 1.4 0.584†
Schirmer’s test (mm) 3.0 ± 2.8 7.8 ± 4.8 0.015†
Corneal fluorescein staining  % 60 0
Data presented as mean ± SD, † = t-test, Corneal fluorescein staining % = percentage of patients
showing corneal fluorescein staining.
46
Table 5. Characteristics of pSS patients and controls (IV).
pSS Controls P-value
Number of patients 20 10 -
Corneal fluorescein staining 1.5 (0.0-4.0) - 0.002‡
Schirmer’s test (mm) 2.5 (1.0-4.8) 9.0 (3.0-10.0) 0.012‡
Tear break-up time (s) 5.0 (3.0-6.0) 7.0 (5.8-12.0) 0.006‡
Mechanical threshold (ml/min) 54.5 + 40.1 85.0 + 24.6 0.036†
Chemical threshold (% -CO2) 29.2 ± 24.0 28.8 ± 14.6 0.960†
Nerve count (nerves/frame) 5.9 ± 2.2 6.1 ± 2.5 0.782†
Stromal nerve thickness (µm) 7.9 (6.4-13.3) 5.7 (3.7-7.3) 0.018‡
VAS (0-100 mm) 61.0 (23.0-80.5) 2.5 (0.0-8.8) 0.000‡
OSDI (0-100 %) 37.5 (20.8-60.8) 5.3 (0.0-12.5) 0.000‡
Data presented as mean ± SD or median and (interquartile range), Mechanical threshold = Corneal
mechanical sensitivity detection threshold, Chemical threshold = Corneal chemical sensitivity detection
threshold, OSDI = Ocular Surface Disease Index, VAS = Visual Analog Scale, † = t-test, ‡ = Mann-
Whitney U- test.
3.3 Corneal sensitivity (IV)
The mean mechanical sensitivity detection threshold was lower in pSS patients, implicating
corneal mechanical hypersensitivity in pSS dry eye. However, no difference was found in
chemical sensitivity detection thresholds (Table 5).
3.4 IVCM in primary Sjögren’s syndrome (III and IV)
Confocal images can be found in the original articles (III and IV) at the end of this thesis.
The surface epithelium was irregular or patchy in the majority of SS corneas (III / Fig. 1A),
whereas control corneas showed normal morphology (III / Fig. 1B). Basal epithelial cells
appeared normal in all subjects.
The subbasal nerve density did not differ between SS and control groups (Tables 4 and 5), as
reflected in long nerve fiber bundles per microscopic field. The normal subbasal nerve plexus of
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a healthy control subject is shown in IV / Figure 1.  Nerve sprouting or a nerve growth cone-like
pattern (III / Figs 2A and 2B; IV / Fig. 2), presumably indicating neural regeneration, was found
at the level of the subbasal nerve plexus in 20-40% of patients. One SS patient with severe
peripheral neuropathy showed very thin subbasal nerve fiber bundles without beading (III / Fig.
2C). Control subjects, by contrast, had relatively thick subbasal nerve fibers. Only a single
highly reflective nerve fiber bundle was observed in one of the control subjects. In addition,
subbasal nerve fiber bundles showed abnormal tortuosity in 2/10 eyes of the SS group (III / Fig.
3B); no such abnormality was seen in the control group (III / Fig. 3D). Interindividual variation
in the density of the subbasal nerve plexus was wide, ranging between 4 and 9 long nerve fiber
bundles per microscopic field. Round particles, measuring approximately 11-12 mm in diameter,
possibly cells of inflammatory origin, were found at the level of the subbasal nerve plexus of
one SS cornea (III / Fig. 3A).
Anterior keratocytes revealed signs of activation, hyperreflectivity, or visible processes in 5/10
SS corneas (III / Fig. 1C).  Interestingly, three of these corneas also showed nerve sprouting (III
/ Figs. 1A and 1B).
The stromal nerves appeared significantly thicker in pSS (IV / Figs 4 and 5) than in controls (IV
/ Fig. 3; Table 5), possibly indicating neural regeneration. In one patient, an extremely thick
stromal nerve measuring 43 µm in diameter was observed (IV / Fig. 5); this patient also
presented with APCs among subbasal nerves and a very low mechanical sensory threshold (10
ml/min), implicating severe corneal hypersensitivity.
Mature APCs with typical branching and long dendritic extensions were observed among the
subbasal plexus of the central cornea in 35% (7/20) of patients (IV / Fig. 6.) but in only 10%
(1/10) of controls. In patients in whom APCs were observed (n = 7), their average density in the
central cornea was 174 ± 26 cells/mm2. The number of mature APCs in the central cornea of
these patients displayed a strong positive correlation with the subjective symptom score (r =
0.847, P = 0.016). Patients with APCs and/or nerve growth cones otherwise did not differ from
other patients with respect to subjective symptoms, objective signs, or other features of nerve
morphology.
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DISCUSSION
1. Tear fluid cytokines and haze after PRK (I)
The cytokines TGF-?1, TNF-?, and PDGF-BB were chosen to be analyzed in tear fluid for their
potential influence on corneal keratocytes and stromal wound healing, including keratocyte
repopulation of the ablated area after initial keratocyte apoptosis, keratocyte activation, and
subsequent production of the ECM (Ohji et al. 1993, Jester et al. 1996, 2002, Wilson et al.
1996a, Andresen et al. 1997, Myers et al. 1997, Andresen and Ehlers 1998, reviewed by Jester
et al. 1999). However, of the measured cytokines, only TNF-? was readily measurable in all
samples at all time-points. TGF-?1 and PDGF-BB were detected in 8/20 and 7/20 preoperative
samples, in 6/19 and 13/19 samples on day 2, and in 7/20 and 10/20 samples at 3 months,
respectively.
Several potential sources exist for tear fluid cytokines, including the main and accessory
lacrimal glands, corneal epithelial and stromal cells, conjunctival or inflammatory cells, the
ECM, and leakage from conjunctival vessels. Corneal wounding seems to result in increased
lacrimal gland mRNA levels for TNF-?, HGF, KGF, and EGF (Thompson et al. 1994, Wilson
et al. 1999b).  Whether the PRK wound induces cytokine production in the human lacrimal
gland is unknown.
No correlations were present between pre- or postoperative tear fluid levels of TGF- ?1, TNF-?,
or PDGF-BB and subepithelial post-PRK haze estimated at 3 months by IVCM. Nor did eyes
with elevated in cytokine concentrations present with higher CMTF haze estimates. The clinical
healing of all eyes proceeded without problems, and the maximal clinical haze observed at 3
months was scored 1 on a scale from +0 to +4. One of the limitations of the study was the small
size of the patient group, with no severe complications, such as dense haze (score +3 or +4)
occurring in this group. The CMTF haze estimates were also low, which might have contributed
to the result. Nevertheless, the observed high cytokine concentrations, e.g. of TGF-?1, in
individual eyes without haze formation may suggest that tear fluid analysis is not optimal for
screening potential candidates for haze formation even had the patient cohort been more
representative in terms of different degrees of subepithelial haze.
2. Nerve regeneration after PRK (I)
During PRK the anterior stromal nerve trunks and subbasal nerve plexus are ablated. Proper
innervation has long been known to be necessary for normal corneal epithelial regeneration
(Beuerman and Schimmelpfennig 1980). In addition, individual epithelial cells and possibly
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also keratocytes are innervated (Muller et al. 1996).  It is, therefore, to be expected that proper
innervation is important for the physiological status of epithelial cells and quiescent keratocytes.
Intriguingly, innervation might have a direct effect on corneal wound healing. To my
knowledge, I am the first to demonstrate that the degree of subbasal nerve plexus regeneration
after PRK in human in vivo cornea positively correlates with restoration of the thickness of
corneal epithelium. This is an additional piece of indirect evidence for the trophic and
regulatory functions of corneal innervation. My observation is in line with earlier in vitro or
experimental findings showing that innervation has an influence on epithelial proliferation
(Araki et al. 1994, Nakamura et al. 1997). Whether nerves also exert an effect on the healing of
stromal tissue remains obscure. No significant correlation was observed between the number of
subbasal nerve fiber bundles and the CMTF haze estimate or the thickness of the haze area.
After the initial anterior keratocyte loss after PRK, the area is repopulated with new migratory
keratocytes (reviewed by Fini and Stramer 2005), which will rapidly transform to altered
keratocytes that produce ECM (Moller-Pedersen et al. 1997). The return of keratocytes to
quiescence takes months (Linna and Tervo 1997, Bohnke et al. 1998, Frueh et al. 1998), and the
timing coincidences with the gradual disappearance of the subepithelial haze (as observed by
slit lamp) and regeneration of innervation. Moller-Pedersen et al. (1997) showed delicate
subbasal nerve fibers in 9/17 patients at 1 month after PRK, whereas according to Frueh et al.
(1998) only 1/18 corneas presented with subbasal nerves at that time. In their study, 7/18
corneas showed nerve regeneration by 4 months and 13/18 corneas by 12 months. Bohnke et al.
(1998) examined 15 eyes at 8-43 months postoperatively and found regenerated nerve fibers in
all eyes. In my study, only two corneas showed a total absence of a subbasal nerve plexus at 3
months, whereas in the other 18 corneas at least single nerve fiber bundles were observed in the
central area, although the branching pattern was not normal by 3 months. However, recovery of
corneal nerve density to preoperative levels took 2 years after PRK (Erie et al. 2005b). There
are certain limitations in grading of neural regeneration, e.g. dense haze impedes the
observation of thin nerve fiber bundles. The resolution of confocal microscopy equipment also
has a limited threshold.
Regrowth of nerve fibers into the ablated area is also essential for restoration of corneal
sensitivity after refractive surgery. After PRK, the central sensitivity, measured using a Cochet-
Bonnet esthesiometer, returns to the preoperative level by 3 months (Perez-Santonja et al. 1999,
Matsui et al. 2001, Lee et al. 2005). Until then, the cornea-lacrimal gland reflex arc, which
regulates tear fluid release from the lacrimal glands, is supposed to be damaged, and several
patients complain about dryness of the ocular surface for the first few months after PRK.
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3. Corneal sensitivity after high myopic LASIK (II)
Corneal mechanical sensitivity detection thresholds over the long term after high myopic
LASIK did not differ from those of control subjects. Accordingly, the results of objective dry
eye tests were similar to those of controls. However, the patients reported ongoing ocular
discomfort and symptoms resembling dry eye (photophobia, grittiness, foreign body sensation,
and ocular irritation) significantly more than age- and sex-matched control subjects. Loss of
sensitivity and recovery of sensitivity after LASIK have been shown to correlate with high
corrections (Kim and Kim 1999, Nassaralla et al. 2003, Bragheeth and Dua 2005, Shoja and
Besharati 2007). It is therefore logical to presume that corneal nerves are implicated in this
process in some way. On the other hand, high correction seems to be one of the risk factors for
patients developing so-called chronic dry eye syndrome after LASIK (reviewed by Albietz and
Lenton. 2004, De Paiva et al. 2006, Shoja and Besharati 2007).
De Paiva and Pflugfelder (2004) found decreased corneal sensitivity after LASIK in patients
without dry eye. They also observed corneal hypersensitivity in patients with post-LASIK dry
eye compared with normal controls. The LASIK group consisted of 20 patients 1-40 months
after myopic or hyperopic correction; data for refractive corrections were not provided. The
post-LASIK dry eye group included six patients who reported dry eye symptoms and had ocular
signs compatible with dry eye after a mean interval of 12 months (range 3–36 months)
following myopic LASIK. The authors suggested that corneal hypersensitivity observed in dry
eye patients is due to compromised ocular surface barrier function and hypersensitivity to air
jet. Some of the differences between their study and my own may be explained by 1) I included
only patients with high myopic corrections, and 2) the mean interval after surgery in my study
was longer (44.2 ± 11.3 months, range 23-58 months).
In addition to decreased reflex and basal tear production, impairment of corneal nerves may
lead to LASIK-induced neurotrophic epitheliopathy (LINE) (Wilson 2001, Wilson and
Ambrosio 2001, reviewed by Ambrosio et al. 2007), where punctate epithelial microerosions
can be detected on the corneal surface. However, patients who developed symptoms and signs
of dry eye after LASIK had no significant difference in tear production detected by Schirmer’s
test with anesthesia from patients who had no symptoms or signs of dry eye at time-points from
1 month to 6 months after surgery (Wilson 2001). LASIK-associated dry eye has been
suggested to represent a neurotrophic epitheliopathy rather than an actual dry eye syndrome
(Wilson 2001). This is supported by the data presented in my study of high myopic LASIK
patients. The majority of patients reported ocular discomfort resembling dry eye symptoms,
although clinical dry eye tests were normal and corneal sensitivity levels were within normal
limits. These symptoms of ocular discomfort could be in part be derived from aberrantly
regenerated corneal nerves.
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LASIK DRY EYE HYPOTHESIS
LASIK patients complain
about ongoing dry eye symptoms
ALTHOUGH...
Some of the symptoms may be
caused by aberrantly
regenerated nerve fibers
?Objective clinicaldry eye tests are normal Mechanical sensitivityis normal
Figure 6. LASIK dry eye hypothesis: in the long term (2-5 years) after high myopic LASIK, the majority
of patients complain about ongoing dry eye –like symptoms.  However, clinical dry eye tests are normal,
and corneal mechanical sensitivity is comparable with that of normal controls. Some of these symptoms
may thus be derived from aberrantly regenerated nerve fibers, representing a form of corneal
neuropathy rather than conventional dry eye disease.
Other issues possibly contributing to dry eye symptoms after LASIK include differences in
corneal curvature; while normal corneas show prolate profiles, i.e. are steeper in the center, high
conventional myopic LASIK produces oblate corneas. These changes in corneal curvature may
interfere with even tear distribution, but mechanical rubbing due to the actual anatomical
change may also be causative.  Mechanical trauma caused by the microkeratome suction ring to
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limbal Goblet cells has been suggested to play a role in LASIK dry eye (Shin and Lee 2006).
Diminished afferent input from corneal nerves also results in a decreased blinking rate, which
may be involved in the pathogenesis of LASIK dry eye (Toda et al. 2001). Moreover, patients
who seek refractive surgery are often contact lens-intolerant and may have preclinical dry eye
before surgery. Unfortunately, my study was cross-sectional and I was not able to conduct
presurgical examinations.
Lay patients are unable to differentiate between symptoms of ocular dryness and "sore eyes"
due to other basic conditions. In the end, however, the most important aspect is the subjective
symptoms experienced by patients. Interestingly, patients report relief in symptoms when using
artificial tears, which may be explained by lowering the frictional forces between lids and the
ocular surface, and thus, the corneal afferent nerves being less activated.
Some of the symptoms experienced may be derived from aberrantly regenerated corneal nerves
after LASIK surgery. LASIK dry eye could in fact be a sort of “phantom pain”, representing a
form of corneal neuropathy rather than conventional dry eye syndrome. This new insight into
the pathogenesis of LASIK dry eye syndrome as a form of corneal neuropathy has clinical
implications and also offers novel therapeutic possibilities. Patients should be informed of the
possibility of developing chronic dry eye symptoms, especially after deep ablations. In severe
cases of disabling chronic pain after LASIK, when conventional therapeutic possibilities fail to
offer relief, consultation of a physician specialized in pain treatment is recommended.
4. Corneal sensitivity in primary Sjögren’s syndrome (IV)
Corneal sensitivity detection thresholds to mechanical air jet stimuli were significantly decreased
in patients with pSS dry eye, implicating corneal hypersensitivity. My finding is in line with
earlier observations by De Paiva and Pflugfelder (2004), who also found decreased mechanical
sensitivity detection thresholds in dry eye measured using a similar modified Belmonte
noncontact gas esthesiometer. By contrast, Bourcier et al. (2005) and Benitez Del Castillo et al.
(2007) reported increased corneal sensitivity detection thresholds in dry eye patients, suggesting
corneal hypoesthesia.
Many variables, such as selection of patients and controls and disease severity, can influence the
results. For example, in the Bourcier study, only one-third of patients had a diagnosis of pSS or
sSS. I included only patients with a diagnosis of pSS and age- and sex-matched controls. In
addition, variability among noncontact gas esthesiometers is inevitable and may explain part of
the discrepancy. We and De Paiva and Pflugfelder (2004) used a modified Belmonte
esthesiometer, while Bourcier et al. and Benitez Del Castillo et al. utilized the original Belmonte
esthesiometer. Differences in the size of the tip, the tip distance to the cornea, and the size of the
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corneal area stimulated by the air jet are important factors. Moreover, therapeutic approaches in
treating dry eye obviously differ. For instance, different use of topical and/or systemic anti-
inflammatory pharmaceuticals during the course of the disease may affect the results.
Decreased corneal sensitivity in dry eye utilizing the Cochet-Bonnet esthesiometer was observed
by Xu et al. (1996) and Villani et al. (2007).  Different results in these cases might be explained
by different research methodologies, as the Cochet-Bonnet esthesiometer uses mechanical
contact probe stimulation with some limitations in sensitivity and reproducibility. In addition, a
mechanical contact probe and a noncontact air jet stimulate corneal afferent sensory nerve
endings differently.
De Paiva and Pflugfelder (2004) suggested that the corneal hypersensitivity observed in dry eye
is due to compromised ocular surface barrier function. In my study, I found a positive correlation
between corneal mechanical sensitivity and increased corneal fluorescein staining, supporting
this part of their hypothesis. In addition, I observed a positive correlation between corneal
morphology, corneal mechanical (hyper)sensitivity, and subjective symptoms, indicating that in
patients with the most severe ocular symptoms weak stimuli are recognized and may even elicit
painful sensations. The findings of altered corneal nerve morphology may offer another
explanation for the observed corneal mechanical hypersensitivity.
5. Corneal nerves in primary Sjögren’s syndrome (II and IV)
Corneal subbasal nerve density was similar between pSS patients and controls (III and IV),
suggesting that this may not per se explain the difference seen in corneal sensation. Previously
published data concerning corneal nerve density in dry eye have been conflicting. Increased
subbasal nerve counts in aqueous tear-deficient patients were observed by Zhang et al. (2005),
whereas decreased nerve counts were reported by Benitez Del Castillo et al. (2004), and (2007)
and Villani et al. (2007). However, in the Benitez Del Castillo studies, a statistically significant
difference was found between the SS group and the control group composed of younger
subjects, but not between the SS group and the control group of older subjects. Although
corneal nerve density is easily calculated and quantified, other properties of the corneal nerves,
such as morphological alterations and inflammatory findings, seem to play a more important
role than nerve density, which may be increased, decreased, or similar compared with controls.
Although corneal subbasal nerve density showed no difference, several morphological
alterations were present in corneal nerves. Nerve growth cone-like structures in subbasal nerves
were found in 20-40% of our patients (III / Figs. 2A and 2B; IV / Fig. 2). These alterations may
implicate ongoing nerve sprouting, and may result from attempts of the inflammation-injured
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nerve fibers to regenerate. Inflammation is recognized as a critical factor in the pathogenesis of
dry eye, and the upregulation of neurotrophins, e.g. nerve growth factor (NGF), during
inflammation has been shown in many studies. NGF is known to induce axonal regeneration,
nerve sprouting, and when overexpressed even hypertrophy of the peripheral nervous system
(Albers et al. 1994). On the other hand, focally applied neutralizing antibodies to neurotrophic
factors reduce collateral axonal branching after peripheral nerve lesion (Streppel et al. 2002).
NGF is expressed in alpha-smooth muscle actin-positive dermal myofibroblasts (Hasan et al.
2000), which are comparable with corneal altered keratocytes. Altered keratocytes develop
during the corneal wound healing process (reviewed by Jester et al. 1999), and in various
inflammatory conditions (reviewed by Petrol et al. 1998, Rosenberg et al. 2002). I observed
altered anterior keratocytes with signs of activation: hyperreflectivity or visible processes, in
5/10 SS corneas (III / Fig. 1C).  Interestingly, the majority of these corneas also showed nerve
growth cone-like structures. Presumably, these altered keratocytes are the source of NGF in SS
dry eye. Recently, it has been shown that patients with dry eye present with elevated tear fluid
levels of NGF (Lee et al. 2006),  and  topical anti-inflammatory treatment with prednisolone
decreases tear fluid NGF levels and markedly alleviates dry eye symptoms (Lee et al. 2006).
Stromal nerves appeared significantly thicker in SS patients than in controls. A similar finding
was reported by Benitez Del Castillo et al. 2004. The implication of the thickening of stromal
nerves remains unclear. However, it has earlier been shown using immunoelectron microscopy
and morphometry that nerve fibers regenerating after an inflammatory insult are significantly
thicker than normal healthy nerve fibers (Imai et al. 1997, Niissalo et al. 2002). Possibly,
stromal nerves are thickened secondary to chronic ocular surface inflammation or this finding
may represent a form of neural regeneration.
Antigen-presenting cells (APCs) play a critical role in corneal immunology in health and
disease (Hamrah et al. 2002, 2003a, 2003b). APCs have been observed in living corneas by
modern IVCM (Rosenberg et al. 2000a, 2002, Zhivov et al. 2005, 2007, Mastropasqua et al.
2006). The density of APCs declines from the limbus to the center in healthy corneas (Hamrah
et al. 2002, 2003b, Zhivov et al. 2005, 2007, Mastropasqua et al. 2006). In the corneal limbal
epithelium, dendritic cells are present in virtually all healthy subjects (Mastropasqua et al.
2006), while in the central cornea only some 20-30% of healthy controls show APCs (Zhivov et
al. 2005, 2007, Mastropasqua et al. 2006). APCs are more often found in the peripheral cornea,
where they show signs of having a mature phenotype with long slender dendritic processes,
while immature APCs without dendrites typically predominate in the central cornea (Zhivov et
al. 2005). We focused on the central cornea and observed APCs in 35% of patients and in 10%
of controls. The density of the APCs in the central cornea in pSS patients was significantly
higher than that reported in healthy subjects (Zhivov et al. 2005, 2007, Mastropasqua et al.
2006). The high APC density together with the mature phenotype of these cells in the central
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cornea (IV / Fig. 6) suggest that these cells are actively involved in the local pathomechanism as
antigen processing and presenting cells. This may contribute to the perpetuation of dry eye and
even lacrimal gland adenitis, as it has recently been shown that desiccating stress exposes
antigenic epitopes shared by the ocular surface and lacrimal glands (Niederkorn et al. 2006).
Primary Sjögren’s syndrome patients presented with corneal mechanical hypersensitivity,
although their corneal nerve density did not differ from that of controls. Corneal sensitivity
appeared to correlate with subjective symptoms and objective ocular signs, but not with corneal
nerve density. However, alterations in corneal nerve morphology (nerve sprouting and
thickened stromal nerves) and an increased number of APCs, implicating the role of
inflammation, were observed. I hypothesize that chronic inflammation and diminished volume
of tear fluid, enriched in pro-inflammatory cytokines such as IL-1 and IL-6 (Tishler et al. 1998,
Solomon et al. 2001), lead to keratocyte activation, which is followed by synthesis of NGF or
other neuronal growth factors. NGF and its high-affinity receptor TrkA are expressed in the
human corneal stroma and epithelium (Lambiase et al. 2000, You et al. 2000). In addition to
hypertrophy of neural tissue (Albers et al. 1994), NGF facilitates transmission of pain
(hyperalgesia), possibly due to its effect on ion channels (Lewin et al. 1993, reviewed by Apfel
2000, Gould et al. 2000). Overexpression of neuronal growth factors could explain not only the
observed changes in corneal nerves and corneal hypersensitivity but also the tenderness – or
even chronic pain and ocular hyperalgesia - often observed in these patients.
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SJÖGREN’S SYNDROME
HYPOTHESIS
Hyperalgesia
Nerve sproutingDegeneration of
epithelium and nerves
Keratocyte activation
Neurotrophins
Chronic ocular
surface inflammation
- Langerhan’s cells
- IL-1, IL-6, etc
Figure 7. Sjögren’s syndrome hypothesis: ongoing ocular surface inflammation along with diminished
tear fluid volume, enriched with pro-inflammatory cytokines, leads to degeneration of the surface
epithelium and subbasal nerves. This results in activation of altered keratocytes, followed by synthesis of
NGF or other neuronal growth factors. Overexpression of neuronal growth factors could explain not
only the observed changes in corneal nerves and corneal hypersensitivity but also the tenderness – or
even the chronic pain and ocular hyperalgesia - often observed in these patients.
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SUMMARY AND CONCLUSIONS
Pre- or postoperative levels of the tear fluid cytokines TGF-?1, TNF-? and PDGF-BB did not
correlate with the development of corneal haze, as estimated by IVCM at 3 months after PRK.
However, it is noteworthy that none of our patients showed severe grade 3 or 4 haze. Subbasal
nerve fibers were observed in the central cornea in 18/20 eyes. A positive correlation was
observed between the regeneration of subbasal innervation (based on the IVCM nerve count at
3 months after PRK) and the thickness of regenerated epithelium, possibly reflecting the trophic
effect of corneal nerves on epithelium. However, the CMTF haze estimate did not correlate with
regeneration of the subbasal nerve plexus.
The majority of patients reported ongoing dry eye symptoms long after high myopic LASIK,
although objective clinical signs were not demonstrable. No difference in corneal sensitivity
was observed between patients and controls. I assume that at least some of the symptoms may
be derived from aberrantly regenerated corneal nerves after LASIK surgery, thus representing a
form of corneal neuropathy rather than conventional dry eye.
Primary Sjögren’s syndrome patients presented with corneal mechanical hypersensitivity,
although their corneal subbasal nerve density did not differ from that of controls. Corneal
mechanical sensitivity appeared to correlate with subjective symptoms and objective ocular
signs, but not with corneal nerve density. However, alterations in corneal nerve morphology
(nerve sprouting and thickened stromal nerves) and an increased number of APCs among
subbasal nerves, implicating the role of inflammation, were observed. We suggest that these
findings offer an explanation for the corneal hypersensitivity or even ocular hyperalgesia often
observed in these patients.
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